DAY 1: Wednesday, July 22, 2015 |
||||||||
Global Biotechnology Congress 2015 and Drug Discovery & Therapy World Congress 2015 July 22nd – 25th, 2015, John B. Hynes Veterans Memorial Convention Center, Boston, USA www.ddtwc.com / www.globalbiotechcongress.com
|
||||||||
TIME |
INAUGURAL
PROGRAM Location:
Ball Room ‘B’ – Level-3 |
|||||||
8:30 - 8:35 am |
Guests to be Seated |
|
||||||
8:35 - 8:45 am |
Welcome Remarks by Chairmen Organizing Committee |
Prof. Ferid Murad (Nobel Laureate) and Prof. Atta-ur-Rahman, FRS |
||||||
Chairman: A. Chapel Co-Chairman: E. Jirillo |
JOINT PLENARY SESSION Location: Ball Room ‘B’ - Level 3 |
|||||||
Time |
Speakers |
Titles |
||||||
8:45 - 9:35 am |
Pamela A. Silver PL-1 |
Designing Biology for a Healthy World
|
||||||
9:35 - 10:25 am |
Phillip A. Sharp (Nobel Laureate) PL-2 |
MicroRNAs, Small Interfering RNAs and Modular Therapeutics
|
||||||
Locations |
Lecture Hall 201 Level 2 |
Lecture Hall 202 Level 2 |
Lecture Hall 203 Level 2 |
Lecture Hall 204 Level 2 |
Lecture Hall 205 Level 2 |
Lecture Hall 206 Level 2 |
Lecture Hall 207 Level 2 |
|
Tracks |
CNS Drug Discovery & Therapy |
Cardiovascular Drug Discovery & Therapy |
Cancer Targeted Drug Delivery |
Diabetes and Obesity Drug Discovery & Therapy |
Regenerative Medicine |
Medical Imaging |
Other Areas (Food, Protein Expression, Clinical Research) / Business Development |
|
Chairman: W.Wang Co-Chairman: T.Y. Chang |
Chairman: R.A.Khalil Co-Chairman: A. Hawkridge |
Chairman:A.Di Pietro Co-Chairman:D.S. Dimitrov |
Chairman:E.Jirillo Co-Chairman:F.Z.Basha |
Chairman:M.O.Hebb Co-Chairman: D.Narmoneva |
Chairman:Y.Zhou Co-Chairman:J.Zhang |
Chairman:J.X.Ma Co-Chairman:C.B. Esselstyn |
||
10:30 - 10:50 am |
10:30 - 11:00 am |
10:30 - 11:05 am |
10:30 - 11:00 am |
10:30 - 11:00 am |
10:30 - 11:00 am |
10:30 - 11:00 am |
||
SL-3 Jia Zhou Development of Serotonin 2C Receptor Positive Allosteric Modulators for Treatment of Neuropsychiatric Diseases |
IL-4 Umesh R. Desai Discovering Antagonists of Glycosaminoglycan-Binding Proteins for Treating Thrombosis, Cancer, and other Diseases
|
KNL-5 Attilio Di Pietro Different Strategies to Target Resistant Cancer Cells Overexpressing Multidrug ABC Transporters: Inhibition and Collateral Sensitivity |
IL-6 Emilio Jirillo Childhood Obesity and Nutritional Interventions
|
IL-7 Tao L. Lowe Mechanically Tunable and Degradable Hydrogels for Regenerative Medicine |
IL-8 Yun Zhou Quantitative Multimodal Multi-parametric Imaging: Its Integration and Applications |
IL-9 JinXia Ma PSP94, Prostasin and PSP94 to Prostasin Signaling in Cancer
|
||
10:50 - 11:10 am |
11:00 - 11:20 am |
11:05 - 11:40 am |
11:00 - 11:30 am |
11:00 - 11:30 am |
11:00 - 11:20 am |
11:00 - 11:20 am |
||
SL- 10 Ta Yuan Chang ACAT1/SOAT1 as a Therapeutic Target for Alzheimer’s and Other Related Neurodegenerative Diseases |
SL-11 Krishna Rajarathnam Chemokines as Drug Targets for Cardiovascular Diseases |
KNL-12 Dimiter S. Dimitrov Therapeutic Monoclonal Antibodies Against Cancer and Viruses
|
IL-13 Matteo A. Russo Role of HIF1α/NFĸB Pathway in Obesity
|
IL-14 Daria Narmoneva Vascular Tissue Regeneration: A Biophysical Perspective on the Role of Mechanical, Molecular and Electric Interactions |
SL-15 Jianhua Zhang Comparison of Two Methods for Semiquantitative Evaluation of DaTSCAN
|
SL-16 Conly Hansen Production of Hydrogen and Methane from Food Processing Waste in Induced Bed Reactors: Experiment and Modeling |
||
11:10 - 11:30 am |
11:20 - 11:40 am |
11:40 - 12:00 noon |
11:30 - 12:00 noon |
11:30 - 11:50 am |
11:20 - 11:40 am |
11:20 - 11:40 am |
||
SL-17 Rina Aharoni From Basic Research to Drug Development – The Story of Copaxone in the Treatment of Multiple Sclerosis, Mechanism of Action, and New Applications |
SL-18 Robert J. Linhardt Re-introduction of Bovine Heparin: Regulatory and Compendial Issues |
SL-19 Hong-tao Xiao Anti-tumor Effect of the Newly Synthesized Hydroxychloroquine Conjugate-AHQ |
IL-20 Jeffrey I. Mechanick The Use of Bariatric Surgery in Patients with Diabetes and Obesity
|
SL-21 Nathaniel Bachrach Native Extracellular Matrix – A Paradigm for Translatable Regenerative Medicine
|
SL-22 Xueqi Chen Multiparametric PET Values in the Prediction of Alzheimer’s Disease Progress |
SL-23 Ivana Orlando Food Science and Biotechnology: Innovative Applications of Non Thermal Technologies in Foods: High Pressure Processing for Increasing the Shelf Life and Sensorial Analysis of Fish and Sea Food |
||
11:30 - 11:50 am |
11:40 - 12:00 noon |
12:00 - 12:20 pm |
12:00 - 12:20 pm |
11:50 – 12:10 pm |
11:40 - 12:00 noon |
11:40 - 12:00 noon |
||
SL-24 Nathali Kaushansky Novel Immunospecific Therapy with Synthetic Multi-Epitope Targeting Agent Modulate MS-like Disease by Induction of Peripheral Regulatory Mechanisms
|
SL-25 Masahiro Sakagami Natural and Synthetic Caffeic Acid-based Oligomers: Anti-oxidative, Anti-e lactase and VEGF Modulatory Activities for Treatment of Emphysema
|
SL-26 Karli Rosner A Highly Efficient In-vivo Therapy for Melanoma and Other Cancer Types |
SL-27 Lex V. der Ploeg Deuterated Polyunsaturated Fatty Acids (dPUFAs) Overcome Lipid Peroxidation Damage in CNS Disorders |
SL-28 Michael Helmrath In vivo Model of Human Intestine
|
SL-29 Rui Gao Associations Between the Alpha-synuclein Spliced Variants and Monoaminergic Degeneration in Parkinson’s Disease |
SL-30 Caldwell B. Esselstyn Plant-Based Nutrition Adherence Strategy Halts Coronary Disease
|
||
11:50 - 12:10 pm |
12:00 - 12:20 pm |
12:20 - 12:40 pm |
|
12:10 – 12:30 pm |
12:00 - 12:20 pm |
12:00 - 12:20 pm |
||
SL-31 Amany A. Abdin Modulatory Effect of Celastrol on Th1/Th2 Cytokines Profile, TLR2 and CD3+ T-lymphocyte Expression in a Relapsing-remitting Model of Multiple Sclerosis in Rats
|
SL-32 Rinku Majumder A Novel, Activated Protein C-independent Role of Protein S in Regulating Thrombosis
|
SL-33 Dror Harats Vascular Targeting System – A Proprietary Gene Therapy Platform Technology |
|
SL-34 Bruno Doiron Syner-III: An In vivo Method to Induce Pancreatic Beta Cell Formation in the Adult Pancreas |
SL-35 Wang Rong-fu Application of Parametric Imaging Using 18F-FDG PET/CT Dynamic Multi-bed Scanning in Differential Diagnosis of Pulmonary Lesions |
SL-36 Mark Nuijten Financial Valuation Algorithm for the Assessment of the Futures Sales of a New Innovative Medicinal Product
|
||
12:10 – 12:30 pm |
|
|
|
|
|
|
||
SL-37 Stefano Gustincich SINEUPs: A New Class of Natural and Synthetic Antisense Long Non-coding RNAs that Activate Translation |
|
|
|
|
|
|
||
LUNCH BREAK:
12:30 – 1:30 pm |
||||||||
Locations |
Lecture Hall 201 Level 2 |
Lecture Hall 202 Level 2 |
Lecture Hall 203 Level 2 |
Lecture Hall 204 Level 2 |
Lecture Hall 205 Level 2 |
Lecture Hall 206 Level 2 |
Lecture Hall 207 Level 2 |
Tracks |
Traditional Chinese Medicine / Genomics |
Cardiovascular Drug Discovery & Therapy / Cancer Targeted Drug Delivery |
Enabling Technologies / Pharmacogenomics / Combinatorial Chemistry / Hot Topics in Natural Products / Biologics / Protein and Peptide Sciences |
Diabetes and Obesity Drug Discovery & Therapy / CNS Drug Discovery & Therapy / Process Chemistry & Drug Manufacturing / Inflammation and Immunology Chemistry |
Regenerative Medicine |
Medical Imaging / Medical Biotechnology |
Other Areas (Marine) / Plant & Environment / Pharmaceutical Biotechnology |
Chairman:W.Wang Co-Chairman:W.Chao |
Chairman:C.Perez-Stable Co-Chairman:S.Ali |
Chairman:M. Helmrath Co-Chairman:J.B.Ulmer |
Chairman:F.Z.Basha Co-Chairman:A.Ejaz |
Chairman: T. L. Lowe Co-Chairman:P.Liu |
Chairman:Y.Zhou Co-Chairman:H.-Y.Jiang |
Chairman:R.J.Linhardt Co-Chairman:B.Dewprashad |
|
1:30 - 2:00 pm |
1:30 - 1:50 pm |
1:30 - 2:05 pm |
1:30 - 2:00 pm |
1:30 - 1:50 pm |
1:30 - 1:50 pm |
1:30 - 1:50 pm |
|
IL-38 Wei Wang Chemical, Pharmacological and Quality Control Studies of Traditional Chinese Medicine (TCM) and Ethnic Medicine |
SL-39 Demetrios Braddock The Molecular Basis of Purinergic Signal Metabolism Regulating Hemostasis and Ectopic Calcification |
KNL-40 Jeffrey B. Ulmer New Technologies for Improved Vaccines Against Infectious Diseases and Cancer
|
IL-41 Fatima Z. Basha Design, Discovery and Synthesis of Novel Non-sugar Based α-Glucosidase Inhibitors as Potential Anti-diabetic Agents |
SL-42 Swathi Balaji Scarless Surgery: Are We There Yet?
|
SL-43 Wang Rong-fu Situation and Progress of Tumor Angiogenesis Targeted Imaging and Therapy via Radionuclide Tracing Techniques |
SL-44 Adela Mora-Gutierrez Influence of Bovine and Caprine Milk-Based Peptides on Exopolysaccharide Synthesis by Streptococcus thermophilus and Lactobacillus delbrueckii ssp. Bulgaricus |
|
2:00 – 2:20 pm |
1:50 – 2:10 pm |
2:05 – 2:25 pm |
2:00 – 2:30 pm |
1:50 – 2:10 pm |
1:50 – 2:10 pm |
1:50 – 2:10 pm |
|
SL-45 Xiong Cai A Naturally-derived Immunosuppressive Drug, Rapamycin, Decreases Circulating Tumor Cells in Patients with Lymphangioleiomy-matosis |
SL- 46 Adam Hawkridge Intact Stable Isotope Labeled Plasma Proteins for Multiplexed LC-MS/MS Quantification
|
SL-47 Prasun J. Mishra Advancing Molecular Diagnostics and Precision Medicine Using Non-coding RNA Variants
|
IL-48 Athar Ata Novel Biomedical Agents from Aboriginal Medicinally Important Plants of Canada |
SL-49 Junwang Xu Mesenchymal Stem Cell Treatment Improves Diabetic Wound Healing through Modulation of MicroRNA Expression |
SL-50 Kuangyu Shi Understanding Tracer Diffusion in Tumor Tissue for Hypoxia Imaging Using Reaction-diffusion Modeling: Matching Computational Simulation to Dynamic [18F]FMISO PET Measurements in Tumors |
SL-51 Patricia A. Sobecky Microbial Response(s) to the 2010 Deepwater Horizon Gulf Oil Spill: a 5-year Study of a Coastal Alabama Salt Marsh |
2:20 - 2:40 pm |
2:10 - 2:45 pm |
2:25 - 2:45 pm |
2:30 - 2:50 pm |
2:10 - 2:30 pm |
2:10 - 2:30 pm |
2:10 - 2:40 pm |
SL-52 Jing Shen Effect of Moxibustion on T Lymphocyte Subsets of Helicobacter pylori-associated Gastritis Rats |
KNL-53 Gautam Chaudhuri Cancer Cells and ATP Generation: Beyond Warburg |
SL-54 Nesterov-Müller Alexander Novel High Density Peptide Arrays with Combinatorial Deposition of Amino Acid Particles for Antibody Profiling |
SL-55 Asma Ejaz Betaine Supplementation Improves Systemic Metabolism and Glycemia in HFD-Fed Mice
|
SL-56 Matthew O. Hebb Autologous Brain Sources for Personalized Cell Therapy in Neurological Disease
|
SL-57 Hong-Yu Jiang Protective Effects of Low Doses Radiation Against Doxorubicin-induced Cardiac Toxicity in Balb/C Mices |
IL-58 Brahmadeo Dewprashad Medicinal Plants Used by Immigrants from the Caribbean
|
2:40 - 3:00 pm |
2:45 - 3:20 pm |
2:45 - 3:05 pm |
2:50 - 3:20 pm |
2:30 - 2:50 pm |
2:30 - 2:50 pm |
2:40 - 3:00 pm |
SL-59 Zhiying Huang Toxicological Finding in Beagle Dogs After a Single or 4 Weeks Oral Gavage of Triptolide |
KNL-60 Rakesh Kumar Targeting MTA1 Master Chromatin Remodeler in Cancer and Stem Cell Biology
|
SL-61 Anita Abedi Novel Platinum Complexes [Pt(N-N)C14], as Suggested Anticancer Drugs |
IL-62 Zhi-Gang Jiang Co-supression of Intracellular Calcium and Oxidative Stress, A Key Strategy for Development of Neuroprotective Drugs |
SL-63 Philip Liu Tracking Regeneration of the Brain After Gene Therapy Using Targeted Guided MRI
|
SL-64 Dalila Naimi Assessment of Crude Extract of Helix Aspersa on Chemo-induced Colitis in Rat |
SL-65 Shin-ichi Kayano Antioxidant Properties of Prunes (Prunus domestica L.) and their Constituents |
3:00 – 3:20 pm |
3:20 – 3:50 pm |
3:05 – 3:25 pm |
3:20 – 3:40 pm |
2:50 – 3:10 pm |
2:50 – 3:10 pm |
3:00 – 3:20 pm |
SL-66 Rui Li The Metabolic and Pharmacokinetic Analysis of Curcuminoids Based on Nanoparticle Formulations by Liquid Chromatography Coupled with Tandem Mass Spectrometry |
IL-67 Carlos Perez-Stable Prostate Cancer-Specific Destruction of Androgen Receptor with Deubiquitinase Inhibitors |
SL-68 Daniel Appella Combionatorial Multivalent Display Using a Synthetic, PNA-based Scaffold to Characterize Ligand-receptor Interactions
|
SL-69 Akila Ramanathan Development of Circadian Rhythm Based Formulation of Atomoxetine Hydrochloride for the Treatment of Attention Deficit Hyperactivity Disorder
|
SL-70 Jian Yang Biodegradable Photoluminescent Polymers and Molecules for Tissue Engineering, Drug Delivery, and Imaging |
SL-71 Hala F.M. Kamel Evaluation of Advanced Glycation end Products (AGEs), Circulating Soluble Receptor for Advanced Glycation End Products (sRAGE) and Oxidized Low-density Lipoproteins (OxLDL) in Hemodialysis Patients |
SL-72 Herry Utomo Biotechnological Approach to Increasing Nutritional Quality in High Yielding Rice
|
3:20 - 3:40 pm |
3:50 - 4:10 pm |
3:25 - 3:45 pm |
3:40 - 4:00 pm |
3:10 - 3:30 pm |
3:10 - 3:30 pm |
3:20 - 3:40 pm |
SL-73 Xue-Fei Tian Study on Anti-Lung Cancer Efficiency of Centipede Extraction In vitro and in vivo |
SL-74 Kirk J. McManus Synthetic Lethal Targeting of Colorectal Cancer Cells through SOD1 Inhibition |
SL-75 M. Younus Rana Residues of Enrofloxacin in Tissues of Freshly Slaughtered Broiler Chickens Available in Local Market of Jhang City (Pakistan) |
SL-76 Kinga Salat Solute Carrier 6A1 (SLC6A1; GAT1) Transporter Subfamily as a Target for Novel Memory Enhancing Drugs
|
SL-77 Shanfeng Wang Injectable and Biodegradable Polymeric Biomaterials for Regenerative Medicine |
SL-78 Sin H. Lee Bring Sanger Sequencing to the Community Clinical Laboratories Worldwide
|
SL-79 Ida Wenefrida Nutritional Quality Enhancement in a Non-GMO High Yielding Rice |
3:40 – 4:00 pm |
4:10 – 4:30 pm |
3:45 – 4:20 pm |
4:00 – 4:20 pm |
3:30 – 3:50 pm |
3:30 – 3:50 pm |
3:40 – 4:00 pm |
SL-80 Wei Li 3D Quality Control of Entire Molecule Complex of Compound Danshen Dripping Pills |
SL-81 Yoko Matsumoto Novel Liposomes Including Trehalose Surfactant Inhibit the Growth of Tumor Cells along with Apoptosis |
KNL-82 Muhammad Iqbal Choudhary Nature-based Drug Discovery – Reemerging Paradigm
|
SL-83 Shyama D. Patel Hypoxia Ischemia in the Neonatal Rat: Therapeutic Hypothermia and Mast Cell Stabilization as Adjunct Pharmacotherapy |
SL-84 Abdul Q. Sheikh Novel Smooth Muscle Cell Progenitors are Primed to Muscularize in Disease |
SL-85 Ekram W. Abd El-Wahab Specific Recognition of the HIV-1 Genomic RNA by the Gag Precursor |
SL-86 Krisztina Szabo The First Extensive Case-study on the Effects of Artificial Mycorrhization of Acer buergerianum Miq. in Hungary |
4:00 - 4:20 pm |
4:30 - 4:50 pm |
4:20 - 4:40 pm |
4:20 - 4:40 pm |
3:50 - 4:10 pm |
3:50 - 4:10 pm |
4:00 - 4:35 pm |
SL-87 Liu Mi Effects of Electroacupuncture on the Ultrastructure of ICC and Expression of Protein CX43 in FD Rats
|
SL-88 James Cleary Overview of the Current and Future Role of Immune Checkpoint Blockade in Oncology
|
SL-89 Adebola O. Oyedeji Anticancer, Antioxidant and Antimicrobial Activities of Some Synthesized Ursolic Acid Derivatives
|
SL-90 Yasuo Iwadate Logical Refinement of Therapeutic Targets for Glioblastoma Based on Multidisciplinary Proteomic Approaches |
SL-91 Mohamed H. Doweidar Numerical Modeling of Mechanotactic Influence on Cell Morphology
|
SL-92 Wei Li Blocking the Function of Inflammatory Cytokines and Mediators by Using IL-10 and TGF-β: A Potential Biological Immunotherapy for Intervertebral Disc Degeneration in a Beagle Model |
KNL-93 Robert J. Linhardt Synthetic and Bioengineered Heparin-based Therapeutics |
4:20 - 4:40 pm |
4:50 - 5:10 pm |
4:40 - 5:00 pm |
4:40 - 5:00 pm |
4:10 - 4:30 pm |
4:10 - 4:30 pm |
4:35 - 4:55 pm |
SL-94 Wang Chao Influence of Electroacupuncture Pretreatment on Serum NO and NOS and Myocardial Ultrastructures in Myocardial Ischemia and Reperfusion Injury
|
SL-95 Darrell R. Borger Multifaceted Approach to Cancer Biomarker Discovery in a Clinical Setting |
SL-96 G.J. Sharma Evaluation of Antioxidant Potentials and Radioprotective Properties of Tropical Ginger in Albino Rats
|
SL-97 Jian-Dong Li Negative Feedback Regulation of Inflammation& Novel Anti-Inflammatory Strategy
|
SL-98 Sandeep Soni Initial Results of Gene Therapy for β-Thalassemia Major via Transplantation of Autologous Hematopoietic Stem Cells Transduced Ex-vivo with a Lentiviral βA-T87Q-Globin Vector |
SL-99 Sarman Singh Application of Newer Molecular Methods for Diagnosing and Drug Resistance Detection in Mycobacterium tuberculosis: Evaluation in Indian Setting |
SL-100 Uttmakumar S. Bagde In vitro Proliferative Effect of Aloe Vera Extracts on Hair Follicles Isolated from the Alopecia Areta Patch |
4:40 – 5:00 pm |
5:10 – 5:30 pm |
5:00 – 5:20 pm |
5:00 – 5:20 pm |
4:30 – 4:50 pm |
4:30 – 4:50 pm |
4:55 – 5:15 pm |
SL-101 Mei-lin Liu Effect of Shenyuan on Anti-inflammatory and Hemodynamic Factors in a Porcine Model of Acute Myocardial Infarction |
SL-102 Nenggang Zhang Sepin-1, A Novel Separase Inhibitor, for Breast Cancer Therapy |
SL-103 Santosh K. Singh Antibacterial Activity and Preliminary Phytochemical Screening of Endophytic Fungal Extract of Rauvolfia serpentina
|
SL-104 Phuong T. Le Direct Arylation and its Application on Scale to the Synthesis of PF-06463922, A Macrocyclic Inhibitor of ALK/ROS1
|
SL-105 David Naor Anti-inflammatory Regenerative Activity of a CD44-derived Peptide |
SL-106 Hongjun Yang Photocross Linkable Maleic Anhydride Acylated Chitosan/Methacryl Poly (Vinyl Alcohol) Nanofibrous Membrane as Potential Wound Dressing for Skin Regeneration |
SL-107 Ella L. Kim The Role of Stem-like Glioma Cells in GBM Progression and Post-treatment Recurrence |
5:00 - 5:20 pm |
5:30 - 5:50 pm |
5:20 - 5:40 pm |
5:20 - 5:40 pm |
4:50 - 5:10 pm |
4:50 - 5:10 pm |
5:15 - 5:35 pm |
SL-108 Meilin Liu Identification of Aspirin Response Related Gene Profiles in the Elderly Population with Coronary Artery Disease |
SL-109 Matthew O. Hebb Intratumoral Modulation Therapy for Glioblastoma |
SL-110 Cid A.M. Santos Uleine
|
SL-111 Jun-ichi Kadokawa Enzymatic Synthesis of Protein-mimic Polysaccharides as Candidate for New Biomedical Materials |
SL-112 Ashim K. Mitra Novel Therapeutic Strategies for Delivering Therapeutics to Brain – Circumventing the Efflux and Permeability Barriers |
SL-113 Huseyin A. Balcioglu Temporomandibular Joint Disorders, Biotechnology and Evolving Trends
|
SL-114 Jaeho Lee Effects of Strong Acid and Ionic Materials on Microwave-assisted Thermo-chemical Hydrolysis of Cattle Manure
|
|
5:50 - 6:10 pm |
5:40 - 6:00 pm |
5:40 - 6:00 pm |
5:10 - 5:30 pm |
5:10 - 5:30 pm |
5:35 - 5:55 pm |
|
SL-115 Cody P. Coyne Synthesis of Covalent Biochemotherapeu-tics with Properties of Selectively “Targeted” Anti-neoplastic Cytotoxicity |
SL-116 Jose C. Martins Understanding Biological Activity and Self-assembly of Antimicrobial Cyclic Lipodepsipeptide Using a Molecular Approach |
SL-117 Michel Baltas Bisvanillin and Bis Aryl Ether Scaffolds for Elaboration of Antiatherogenic Agents; Synthesis and Biological Activities |
SL-118 Somaya Hosny Potential Therapeutic Effect of Hematopoietic Stem Cells on Cerebellar Ataxia in Adult Female Rats Subjected to Cerebellar Damage by Monosodium Glutamate |
SL-119 Nilufer Balcioglu Finite Element Analysis in Oral Implantology |
SL-119(a) Im-Gyu Byun Variation of Algae Occurrence Before and After Weir Construction at Mulgeum Site in Downstream the Nakdong River, South Korea |
|
|
|
|
5:30 - 5:50 pm |
5:30 - 5:50 pm |
|
|
|
|
|
SL-120 Qiaobing Xu Nanoparticles for Neural Regeneration |
SL-121 Amanda Arnold Convergence: A Transformative Approach to Advanced Research at the Intersection of the Life Physical and Engineering Sciences |
|
COFFEE BREAK:
6:00 – 6:45 pm |
DAY 2: Thursday, July 23, 2015 |
||||||||||||||
Chairman: C. N. Serhan |
JOINT PLENARY SESSION |
|||||||||||||
Time |
Speakers |
Titles |
||||||||||||
8:30 - 9:20 am |
Ferid Murad (Nobel Laureate) PL-122 |
Application of Nitric Oxide Research to Drug Development |
||||||||||||
9:20 - 10:10 am |
Martin Nowak PL-123 |
Evolutionary Dynamics and Treatment of Cancer |
||||||||||||
Locations |
Lecture Hall 201 Level 2 |
Lecture Hall 202 Level 2 |
Lecture Hall 203 Level 2 |
Lecture Hall 204 Level 2 |
Lecture Hall 205 Level 2 |
Lecture Hall 206 Level 2 |
||||||||
Tracks |
Drug Discovery in Preclinical Research
|
Cardiovascular Drug Discovery & Therapy |
Innovative Drug Discovery & Nanotechnology |
In Silico Drug Design & In Silico Screening |
Regenerative Medicine |
Pharmaceutical Biotechnology |
||||||||
Chairman: W.B.Weglicki Co-Chairman: S. Neumann |
Chairman: R.A.Khalil Co-Chairman: R.J.Linhardt |
Chairman: S.De Paoli Co-Chairman: E.S.Don |
Chairman: J.Skolnick Co-Chairman: M.Shalaeva |
Chairman: A.Q.Ye Co-Chairman: W.J. Rowe |
Chairman: R.S.Ferreira Co-Chairman: M.Cai |
|||||||||
10:20 - 10:50 am |
10:20 - 10:50 am |
10:20 - 10:50 am |
10:20 - 10:55 am |
10:20 - 10:50 am |
10:20 - 10:50 am |
|||||||||
IL-124 Eugene L.P. Chekler Tissue Selective Androgen Receptor Modulators (SARMs): A Path to a Clinical Candidate
|
IL-125 Raouf A. Khalil Role of Microvascular Endothelial Type B Endothelin Receptor During Pregnancy Implications in Hypertensive Pregnancy and Preclampsia |
IL-126 Jean-Pierre Leburton Genomics with Graphene Nanotechnology
|
KNL-127 Jeffrey Skolnick On the Origin and Completeness of Ligand Binding Pockets with Applications to Drug Discovery
|
IL-128 Adam Q. Ye Controlled Released Scaffolding Biomaterial for Bone Tissue Engineering: A Novel Therapeutic Strategy for Clefts Patients
|
IL-129 Alain Chapel Stem Cell Therapy for the Treatment of Severe Tissue Damage after Radiation Exposure |
|||||||||
10:50 - 11:20 am |
10:50 - 11:10 am |
10:50 - 11:10 am |
10:55 - 11:25 am |
10:50 - 11:20 am |
10:50 - 11:10 am |
|||||||||
IL-130 Tove Tuntland Target Based vs. Phenotypic Screening Approaches in Drug Discovery |
SL-131 Ruomei Qi Ginkgolide B Reduces TLR4 and Inflammatory Protein Expression in Glucose-Treated HUVECs
|
SL-132 Rashid Bashir Nanopore-Based Detection of Biomarkers for Cancer Diagnostics
|
IL-133 Marina Shalaeva Useful Descriptors in Beyond Rule-of-Five Drug Design Space?
|
IL-134 William J. Rowe The Neil Armstrong Space Syndrome
|
SL-135 Rasha F. Mady The Evaluation of Cercarial Transformation Fluid Used Singly and in Combination with Curde Cercarial Antigen in Experimental Schistosomiasis mansoni |
|||||||||
11:20 - 11:40 am |
11:10 - 11:30 am |
11:10 - 11:30 am |
11:25 - 11:45 am |
11:20 - 11:50 am |
11:10 - 11:30 am |
|||||||||
SL-136 Joerg Eder Discovery of First-in-class Drugs: Target- and Systems-based Approaches
|
SL-137 Jan Torzewski Inhibiting C-reactive Protein for the Treatment of Cardiovascular Disease – Way into Clinical Studies |
SL-138 Marija Drndic Biomolecule Analysis and DNA Sequencing with Solid-state Nanopores |
SL-139 Hua Gao Integration of In Silico Prediction in Drug Discovery Process
|
IL-140 Jeffrey Harrison Personalized Healthcare: from Research to Reality
|
SL-141 Fuad Fares Long Acting Analogs of Glycoprotein Hormones Designed by Site-directed Mutagenesis and Gene Fusion |
|||||||||
11:40 - 12:00 noon |
11:30 - 11:50 am |
11:30 - 11:50 am |
11:45 - 12:05 pm |
11:50 - 12:10 pm |
11:30 - 11:50 am |
|||||||||
SL-142 Peter Wookey Targeting Calcitonin Receptor Expressed by Brain Tumour Initiating Cells of Glioblastoma Multiforme |
SL-143 Martin Safo Rationally Designed Allosteric Effectors of Hemoglobin Exhibit Superior Antisickling Properties |
SL-144 Michael A. Stroscio Nanotechnology-based Tools for the Study of the Affinity and Selectivity of Antigens for Small Molecular Targets Underlying Drug Discovery and Therapeutics |
SL-145 Franco Lombardo Computational Approaches to PK-Friendly (Drug-like) Molecules
|
SL-146 Bogdan M. Wozniewicz Human Thymus Derived Progenitor/Stem Cells Immunotherapy in Autoimmune Diseases
|
SL-147 Gloria N. Okwu Hypolipidemic and Hypoglycemic Activities of Ethanol Extract of Cyperus rotundus Rhizome |
|||||||||
12:00 - 12:20 pm |
11:50 - 12:10 pm |
11:50 - 12:10 pm |
12:05 - 12:25 pm |
12:10 - 12:30 pm |
11:50 - 12:10 pm |
|||||||||
SL-148 Alexey Rak The Use of Microscale Thermophoresis, Virtual Screening and Thermal Shift Assays for the Rapid Identification of Fragments Active Against Human Kinase |
SL-149 Jian Liu Chemoenzymatic Synthesis of Low Molecular Weight Heparins |
SL-150 Milana C. Vasudev Peptide Nanotubes for the Non-invasive Detection of Biomolecule Secretion from Cells |
SL-151 Oleg Reva Similarity and Difference in Mechanisms of Action of Antistaphylococcal Antibiotics Mupirocin and Batumin Revealed by in Silico Molecular Docking |
SL-152 Marianne Ellis Scale-up of Immune Cell Therapies for Organ Transplants
|
SL-153 Chetana Roat Endophytic Fungus as a Source of Bioactive Secondary Metabolites: Resveratrol and Viniferin
|
|||||||||
12:20 - 12:40 pm |
12:10 - 12:30 pm |
12:10 - 12:30 pm |
|
|
12:10 - 12:30 pm |
|||||||||
SL-154 Lexie S. Holliday Rational Identification of Enoxacin as a Novel V-ATPase (and/or MicroRNA?)-directed Osteoclast Inhibitor |
SL-155 Agnes Azimzadeh Synthetic Heparan Sulfate Mimetics as Novel Anticoagulants: In vitro Evaluation for Xenotransplantation |
SL-156 Georgeta Crivat Nanoparticle Based Sensors with Biological Applications
|
|
|
SL-157 Rui S. Ferreira Junior Molecule Drug Candidates – Prospecting, Development, Optimization and Clinical Trials: Two Brazilian Successful Cases |
|||||||||
LUNCH BREAK: 12:30
– 2:00 pm |
||||||||||||||
Locations |
Lecture Hall 201 Level 2 |
Lecture Hall 202 Level 2 |
Lecture Hall 203 Level 2 |
Lecture Hall 204 Level 2 |
Lecture Hall 205 Level 2 |
Lecture Hall 206 Level 2 |
||||||||
Tracks |
Drug Discovery in Preclinical Research |
Stereoselective Synthesis of Bioactive Compounds / Inflammation and Immunology / Translational Medicine / Biologics |
Bioactive Lipids / High Throughput Screening & Laboratory Automation / Medical Imaging / Drug Metabolism / Hot Topics in Drug Targets / Proteomics & Bioinformatics |
In Silico Drug Design & In Silico Screening/ Academic CRO – Industrial Collaborations in Drug Discovery / Recent Advances in Patient Treatment & Care
|
Plant & Environment |
Pharmaceutical Biotechnology
|
||||||||
Chairman: T.Tuntland Co-Chairman: E.L.P.Chekler |
Chairman: S. Premawansa Co-Chairman: S.Ari |
Chairman: M.Linder Co-Chairman: W.A. Zaghary |
Chairman: E.P. Hoffman Co-Chairman: T.D.Y.Chung |
Chairman: Q. Liu Co-Chairman: L.Ji |
Chairman: N.L.Parenteau Co-Chairman: Y.J.Rosenberg |
|||||||||
2:00 - 2:35 pm |
2:00 - 2:20 pm |
2:00 - 2:20 pm |
2:00 - 2:20 pm |
2:00 - 2:30 pm |
2:00 - 2:35 pm |
|||||||||
KNL-158 William B. Weglicki Prevention of EGFR-Tyrosine Kinase Inhibitor Complications by Treatment with NK-1 Receptor Blockade |
SL-159 Xiang Liu Total Synthesis of 6-Deoxypladienolide D and Assessment of Splicing Inhibitory Activity in a Mutant SF3B1 Cancer Cell Line |
SL-160 Messaouda Kaci Nanoencaosulation of Coenzyme Q10 by a New Emulsification Process Used in Cosmetic |
SL-161 Mustafa Guzel Novel Drug Canditates for Type-2 Diabetes Mellitus (T2DM): From Bench to Bedside |
IL-162 Qing Liu Characterization of an Exceptionally Large FAD2 Gene Family and Development of Super High Oleic Genotype in Safflower |
KNL-163 Muhammad I. Choudhary Creating Bioactive Chemical Space by Biotransformation |
|||||||||
2:35 - 3:05 pm |
2:20 - 2:50 pm |
2:20 - 2:40 pm |
2:20 - 2:55 pm |
2:30 - 2:50 pm |
2:35 - 3:05 pm |
|||||||||
IL-164 Jetze J. Tepe Expanding Chemical Space Beyond Drugability-rules: The Search for Mechanistically Distinct Proteasome Inhibitors |
IL-165 Sunil Premawansa Nitrogen and Oxygen Intermediates and Antibody Mediated Platelet Cytotoxicity as Prognostic Markers for Dengue Severity |
SL-166 Michel Linder Morphological and Biophysical Properties of Natural Phospholipidsbased Biomembranes |
KNL-167 Eric P. Hoffman VBP15 for DMD: A Collaborative Public/Private Partnership Enabled by Venture Philanthropy Support from the International Stake-holder Community |
SL-168 Steve Jobling The Role of Cellulose-synthase-like CsIF6 in 1,3;1,4-β-D-glucan Biosynthesis and Overexpression in Wheat Grain to Increase Soluble Dietary Fiber Levels |
IL-169 Anton Buzdin Novel Approach for Big Data Management at the Level of Intracellular Signalization and its Applications to Biomedicine, Drug Discovery and Personalized Therapy |
|||||||||
3:05 – 3:35 pm |
2:50 – 3:10 pm |
2:40 – 3:00 pm |
2:55 – 3:25 pm |
2:50 – 3:10 pm |
3:05 – 3:25 pm |
|||||||||
IL-170 Susanne Neumann Small-molecule “drug-like” TSH Receptor Agonists and Antagonists |
SL-171 Abu Salim Mustafa Immune Responses to Candidate Vaccine Antigens Delivered through Naked Plasmids and Mycobacterial Vectors |
SL-172 Nitish Agrawal Development of Novel Class of M1 ERAP Aminopeptidase Inhibitors for Treating Autoimmune Diseases
|
IL-173 Thomas D.Y. Chung Open Innovation in Drug Discovery & Translational Research in Academia
|
SL-174 Zachary Demorest Highly Efficient Genome Editing for Crop Improvement
|
SL-175 Yvonne J. Rosenberg Pharmacokinetics and Immunogenicity of Plant-derived Broadly Neutralizing HIV Monoclonal Antibodies in Macaques |
|||||||||
3:35 - 3:55 pm |
3:10 - 3:30 pm |
3:00 - 3:20 pm |
3:25 - 3:45 pm |
3:10 - 3:30 pm |
3:25 - 3:45 pm |
|||||||||
SL-176 Henry Yu Discovery of Orally Active FSHR Allosteric Modulators
|
SL-177 Chanika D. Jayasinghe In vivo and In vitro Immunostimulatory Activity of Sri Lankan Wild Type Carica Papaya L. Mature Leaf Concentrate in Rats |
SL-178 Liqin Du Identifying Novel Differentiation Agents for Neuroblastoma Therapy |
SL-179 Andrew D. Badley New Frameworks for Translational Research at the Mayo Clinic: Center for Clinical & Translational Sciences (CCATS) |
SL-180 Rachel Amir Evidence of Metabolic Competition between Methionine and Glutathione Biosynthetic Pathways |
SL-181 Alexei Yeliseev Human Cannabionoid Receptor CB2: Expression, Functional and Structural Studies
|
|||||||||
3:55 – 4:15 pm |
3:30 – 3:50 pm |
3:20 – 3:40 pm |
3:45 - 4:05 pm |
3:30 – 3:50 pm |
3:45 – 4:05 pm |
|||||||||
SL-182 Zaneta Nikolovska-Coleska Discovery and Development of Small Molecule Modulators of Apoptosis as New Anticancer Drugs
|
SL-183 Agnes M. Azimzadeh Targeting Immune Costimulation Using a Novel αCD28 Peggylated Fab and CD154 Blockade: Efficacy in a Pre-Clinical Transplant Model |
SL-184 Sulei Zhang First Multi-site Study on Quantitative Dynamic Whole-body FDG PET-CT in Oncologic Imaging |
SL-185 Ralph J. Garippa Friends with Benefits: Why Partnering with an Academic CRO Makes Ultimate Sense
|
SL-186 Abed A.M. J. Almanssoori RAPD-PCR Analysis of Indigenous Iraqi Sinorhizobium meliloti Isolates Differing in their Ability to Drought Tolerance |
SL-187 Shi Jiancheng MTDLs Design on Acetylcholinesterase (AChE) and β-secretase (BACE-1): 3D-QSAR and Molecular Docking Studies Globin Vector |
|||||||||
4:15 - 4:35 pm |
3:50 - 4:10 pm |
3:40 - 4:00 pm |
4:05 - 4:25 pm |
3:50 - 4:10 pm |
4:05 - 4:25 pm |
|||||||||
SL-188 Hiroshi Nagase Design and Synthesis of Novel δ Opioid Agonists and their Pharmacologies
|
SL-189 Madhu Chopra Synergistic Effect of HDAC Inhibitor (Panobinostat) and Topoisomerase Inhibitors on Cervical Cancer Cells |
SL-190 Wafaa A. Zaghary Preliminary Assessment on 99mTc-salmeterol Xinafoate as a Potential Bone-imaging Agent |
SL-191 Edward Kahn When Open Innovation Meets Repurposing
|
SL-192 Rachel A. Burton The Deconstruction of Seed Mucilages
|
SL-193 Chong K. Phin Antibacterial Activity, Mechanism of Action and Phytochemical Studies of Cynodon Dactylon (L.) Pers. Solid Phase Extract (SPE) Against Some Bacterial Pathogens |
|||||||||
4:35 – 4:55 pm |
4:10 – 4:30 pm |
4:00 – 4:30 pm |
4:25 – 4:45 pm |
4:10 – 4:30 pm |
4:25 – 4:45 pm |
|||||||||
SL-194 Edward Holson Development of a β-arrestin Biased D2R Antagonist for the Treatment of Schizophrenia |
SL-195 Thomas Herz A Full-360-Translational Pharmacology Concept – From Pre-Clinical Experiments to Clinical Data and Back |
IL-196 Esmaiel Jabbari Synthesis of Hydrolysable Nanogels for Controlled Temporal Delivery of Vasculogenic Factors in Patterned Cellular Constructs |
SL-197 Stephen Freedman Exploring New Ideas for the Academic Industry Interface
|
SL-198 Lianghui Ji A Whole Plant Approach for Nitrogen-fixation in Non-leguminous Crops
|
SL-199 Rachel G. Lichtenstein Inhibition of the IgG-FcγRIIIA Interactions in mSOD1 Mice Prolonging Mouse Survival |
|||||||||
4:55 - 5:15 pm |
4:30 - 4:50 pm |
4:30 - 4:50 pm |
4:45 - 5:05 pm |
4:30 - 4:50 pm |
4:45 - 5:05 pm |
|||||||||
SL-200 Daniel Appella Targeting HIV Nucleocapsid Protein via a Small Molecule Platform and Related Preclinical Development
|
SL-201 Jamal Zidan Vascular Endothelial Growth Factor Expression Compared to Clinical and Pathological Features in Ovarian Cancer |
SL-202 Divya Samineni Use of Physiologically-based Pharmacokinetic (Pbpk) Modeling to Assess Drug Interaction Potential of Antibody-drug Conjugates (Adcs) |
SL-203 Oluwatoyin A. Odeku Formulation of Floating Gastroretentive Metronidazole Microspheres Using Cassava Starch (Manihot Esculenta) as Polymer
|
SL-204 Joanna D. Mankiewicz-Boczek Increasing the Efficiency of Nitrogen Compounds Removal from Agricultural Areas through the Optimization of Conditions for Microbial Activity |
SL-205 Tian Wang The Development of a High Resolution LC-MS Peptide Mapping Method for Automated Quantification of N-linked Glycans in Immunoglobulins |
|||||||||
5:15 – 5:35 pm |
4:50 – 5:10 pm |
4:50 – 5:10 pm |
5:05 – 5:25 pm |
4:50 – 5:10 pm |
5:05 – 5:25 pm |
|||||||||
SL-206 Jia Zhou Developing Small-molecule Bax Activators for Cancer Therapy |
SL-207 Mehrdad Modaresi Effect of Althaea officinalis L. Root Extract on Concentration of Blood Proteins in Mice
|
SL-208 Keltoum Anflous-Pharayra VDACs Deficient Mice: An Original Model to Target Selectivity Metastasis
|
SL-209 Ke Cheng Development of a Cloud-based Histology Database for Collaborative Cancer Research |
SL-210 Rainer Fischer Plant-Based Biopharmaceuticals for Emergency Responses and Alternative Rapid Production of Novel Biopharmaceuticals |
SL-211 Smail Meziani PAOT Technology® New Approach for Determination of Oxidative Stress Status of Biological Liquids and Tissues |
|||||||||
5:35 - 5:55 pm |
5:10 - 5:30 pm |
5:10 - 5:30 pm |
5:25 - 5:45 pm |
5:10 - 5:30 pm |
5:25 - 5:45 pm |
|||||||||
SL-212 Andres E. Dulcey Discovery, Optimization, and Characterization of Novel Chlorcyclizine Derivatives for the Treatment of Hepatitis C Virus Infection
|
SL-213 Sule Ari Bioactive Properties of Turkish Endemic Astragalus chrysochlorus |
SL-214 Mehmet E. Buyukbingol 3D Analysis of the Binding Sites for Predicting Binding Affinities in Drug Design |
SL-215 Jennifer Smith ICCB-Longwood: Examples of How an Academic Screening Core can Enable Industry Collaborations |
SL-216 Jamshid Jazestani Harnessing Microbial Interaction for Increasing Crop Productivity in Semiarid Prairie Agricultural Region of Western Canada |
SL-217 Jun Shao Non-invasive Delivery of Biotechnological Drugs |
|||||||||
5:55 - 6:15 pm |
5:30 - 5:50 pm |
5:30 - 5:50 pm |
5:45 - 6:05 pm |
5:30 - 5:50 pm |
|
|||||||||
SL-217(a) Jerrie S. Refuerzo NanoscaleDrug Carrying Systems to Prevent Placemental Passage of Harmful Drugs to the Fetus in a Pregnant Rodent Model
|
SL-218 Sadhna Sharma In Silico Identification of Promiscuous CTL Epitopes of mymA Operation Protains of Mycobacterium tuberculosis for a Epitope Based Vaccine Design |
SL-219 Elie Hadchity Kruppel Like Factors and Heat Shock Protein 27: New Potential Markers of Larynx and Lung Carcinomas |
SL-220 Almeriane M. Weffort-Santos Uleine, A Booster of the Immune Response: Activity on AIDS Patients |
SL-221 Rasha F. Mady Microsporidia and Zingiber officinale (Ginger); an Emerging Parasite and an Old Medicinal Plants: In vivo Trial |
|
|||||||||
COFFEE BREAK:
6:00 – 6:45 pm |
||||||||||||||
DAY 3: Friday, July 24, 2015 |
|||||||||
Chairman:
Atta-ur-Rahman |
JOINT PLENARY SESSION |
||||||||
Time |
Speakers |
Titles |
|||||||
8:30 - 9:20 am |
Bernhard O. Palsson PL-222 |
Reconstruction, Modeling and Use of Genome-scale Networks in Biology |
|||||||
9:20 - 10:10 am |
Charles N. Serhan PL-223 |
Novel Pro-resolving Lipid Mediators in Inflammation & Infection Leads for Resolution Physiology and Pharmacology |
|||||||
10:10 - 11:00 am |
Shuji Ogino PL-224 |
Emerging Pharmaco-MPE (Molecular Pathological Epidemiology) Paradigm for Global Precision Medicine |
|||||||
POSTER
SESSION & LUNCH BREAK: 11:00 – 1:00 pm |
|||||||||
Locations |
Lecture Hall 201 Level 2 |
Lecture Hall 202 Level 2 |
Lecture Hall 203 Level 2 |
Lecture Hall 204 Level 2 |
Lecture Hall 205 Level 2 |
||||
Tracks |
Anti-Infectives / Pharmaceutical Research & Development / Nutraceutical Drug Discovery & Therapy / Inflammation and Immunology / Chemistry |
Neurodegenerative Disorders / CNS Drug Discovery & Therapy |
Hot Topics in Medicinal Chemistry / Regenerative Medicine |
Medical Biotechnology / Pharmaceutical Biotechnology / Other Areas (Microrobot, Food, Protein Expression, Nanobiotechnology, Marine, Systems Biology) / Marine Biotechnology |
Plant & Environment / Industrial & Manufacturing |
||||
Chairman: M.G.Moloney Co-Chairman: R.Chaguturu |
Chairman: D.K.Lahiri Co-Chairman: F.Checler |
Chairman: C.McInnes Co-Chairman:D.S.Rawat |
Chairman: H.U.Shekhar Co-Chairman: K.Saito |
Chairman: I.J.Diaz-Maroto Co-Chairman: P. (Patrick) Fu |
|||||
1:00 – 1:35 pm |
1:00 – 1:35 pm |
1:00 – 1:30 pm |
1:00 – 1:20 pm |
1:00 – 1:30 pm |
|||||
KNL-225 Mark G. Moloney Equisetin, Reutericyclin and Streptolodygin: Natural Product Lead Structures for Novel Antibiotics |
KNL-226 Debomoy K. Lahiri Seeing a Road from the CAR: Could Effective microRNA “brakes” Slow Down the Trip to Alzheimer’s Disease? |
IL-227 Campbell McInnes Fragment Based Design of Non-ATP Competitive Kinase Inhibitors through REPLACE
|
SL-228 Ian D. Dickey Transcutaneous Applications of Foam Metals
|
IL-229 Ignacio J. Diaz-Maroto Identification of Botanical Origin of Natural Woods Used in Wine Aging |
|||||
1:35 - 1:55 pm |
1:35 - 2:05 pm |
1:30 - 1:50 pm |
1:20 - 1:40 pm |
1:30 - 1:50 pm |
|||||
SL-230 Hidayat Hussain New Strategies for Fighting Malaria
|
IL-231 Frederic Checler Presenilins are Transcriptional Targets of Parkin |
SL-232 Kenneth W. Duncan Targeting the Arginine Methyitransferases |
SL-233 Akio Mori Targeting CD28 Signal for Steroid Resistant Asthma
|
SL-234 James Petrie A New Plant Oil Production Platform: Seed-like Oil Yield from Biomass |
|||||
1:55 – 2:15 pm |
2:05 – 2:35 pm |
1:50 – 2:10 pm |
1:40 – 2:00 pm |
1:50 – 2:10 pm |
|||||
SL-235 Mouloud Kecha Antibacterial Polyketide from the Marine Alga-derived Endophitic Streptomyces sundarbansensis: A Study on Hydroxypyrone Tautomerism |
IL-236 Sultan Darvesh Butyrylcholinesterase as a Diagnostic and Therapeutic Target for Alzheimer’s Disease
|
SL-237 Ernst Schonbrunn Development of Potent Dual Bromodomain-kinase Inhibitors for Cancer Therapy |
SL-238 Xiaoming Wang The Expression of Plasma miR-199a-5p,miR-200c-3p in Gastric Carcinoma and its Clinical Significance |
SL-239 Sang-Soo Kwak Metabolic Engineering of Carotenoids in Transgenic Sweetpotato for Sustainable Development on Global Marginal Lands |
|||||
2:15 - 2:35 pm |
2:35 - 3:05 pm |
2:10 - 2:30 pm |
2:00 - 2:20 pm |
2:10 - 2:30 pm |
|||||
SL-240 Mukhtar Dauda Comparison of In vivo and In vitro Tests of Resistance in Plasmodium falciparum Positive Patients Treated with Artemisinin Based Combination Therapy in Northwestern Nigeria
|
IL-241 Nigel Greig New Pharmacological Tools to Understand and Experimental Drugs to Treat Mild Traumatic Brain Injury and Related Disorders
|
SL-242 Diwan S. Rawat Molecular Hybrids: An Innovative Approach in Drug Discovery
|
SL-243 Weilin Xu The Physical Properties and Biocompatibility of Biomedical Polyurethane Reinforced by Native Silk Fibroin Powder
|
SL-244 Zahid Ali Genetic Stability and Persistence of Morphological Features of Transgenic Pea (Pisum sativum L.) Harboring Na+ Antiporter Against Salt Stress |
|||||
2:35 – 2:55 pm |
3:05 – 3:25 pm |
2:30 – 2:50 pm |
2:20 – 2:40 pm |
2:30 – 2:50 pm |
|||||
SL-245 Mei X. Wu Effective and Lesion-free Cutaneous Influenza Vaccination |
SL-246 Xudong Huang A Brain-permeable Antioxidant Targeting Aβ Amyloid Pathology
|
SL-247 Eileen J. Kennedy Inhibiting EGFR Dimerization Using Triazolyl-bridged Dimerization Arm Mimics |
SL-248 Hyung-Kwon Lim Engineering of Novel Domain Antibody Scaffold Using In vivo Protein Folding Pathway
|
SL-249 Seema Sambrani Bioaugmentation of Crude Oil Spills: Bioremediation with a Microbial Formula Tailored with Selected Solvent Tolerant Native Strain |
|||||
2:55 - 3:30 pm |
3:25 - 3:55 pm |
2:50 - 3:10 pm |
2:40 - 3:00 pm |
2:50 - 3:10 pm |
|||||
KNL-250 Rathnam Chaguturu Scientific Misconduct in Biomedical Sciences
|
IL-251 Jeff Kuret Imaging Agents for Diagnosis of Neurodegenerative Diseases
|
SL-252 Damith G. Udugamasooriya Peptoid-combinatorial Strategies to Target Non-protein Biomarkers in the Tumor Microenvironment
|
SL-253 Ken Saito Biotechnological Approach of MEMS Microrobot System with Artificial Neural Networks Integrated Circuit |
SL-254 Ming Y. Zheng The Significance of Doubled Haploid Production via Microspore Embryogenesis in Plant Biotechnology and Crop Breeding |
|||||
3:30 - 3:50 pm |
3:55 - 4:15 pm |
3:10 - 3:30 pm |
3:00 - 3:20 pm |
3:10 - 3:30 pm |
|||||
SL-255 Stanislav Pavelka Iodothyronine Deiodinases: Determination of their Activities by Novel Radiometric Enzyme Assays
|
SL-256 Cynthia Lemere Alzheimer's Disease Vaccines: Breakthroughs and Setbacks
|
SL-257 Venkat Subramanian Novel Inhibitors and Chemical Probes to Study the Protein Arginine Deiminases (PADs)
|
SL-258 Shlomit Kenigsberg The Need for Optimization: Overview of Extracellular Vesicles (EVs) Isolation Techniques from Small Volumes of Serum and Reproductive Biological Fluids |
SL-259 Satyawati Sharma Bioremediation of Heavy Metal Polluted and Salt Affected Soils Employing Arbuscular Mycorrhizal Fungi |
|||||
3:50 – 4:10 pm |
4:15 – 4:35 pm |
3:30 – 4:00 pm |
3:20 – 3:40 pm |
3:30 – 3:50 pm |
|||||
SL-260 Araz Raoof From Patients Biospecimens to Therapeutic Solutions: New Departure in Drug Discovery
|
SL-261 Jack Rogers Cooperative RNA Modulation of Neurodegenerative Disease Transcripts to Improve Iron Homeostasis while also Providing Anti-amyloid Efficacy |
IL-262 Denise de Oliveira Silva Developing Strategies to Build Combined Diruthenium-pharmaceutical Metallodrugs Targeting Cancer Therapy |
SL-263 Alexander Trofimov Helio-hero Protected Drink-water and Food: The New Possibilities and Perspectives of the Preventive Medicine |
SL-264 Katsuhiro Shiratake Multi-omics Study on Anthocyanin and Resveratrol Accumulations in Grape Berry Skin and Culture Cells
|
|||||
4:10 - 4:30 pm |
4:35 - 5:05 pm |
4:00 - 4:30 pm |
3:40 - 4:00 pm |
3:50 - 4:10 pm |
|||||
SL-265 Shamsher Ali Bottom-up Approaches for Polymeric Vasculature Tissue Constructs and Cellular Microenvironment |
IL-266 Kumar Sambamurti Dietary Restriction to Prevent AD Pathogenesis
|
IL-267 James B. Hoying Microvessel Adaptation and Plasticity in Microvascular Regeneration
|
SL-268 Fayyaz Rasool ATPase 6/8 Gene Assisted Genetic Variability Studies Among the Population of Labeorohita
|
SL-269 Sujing Li Novel Application of Sargassum as a Potential Waste Derived Catalyst for Low Temperature Selective Catalytic Reduction of Nitric Oxides |
|||||
4:30 – 4:50 pm |
5:05 – 5:35 pm |
4:30 – 5:00 pm |
4:00 – 4:20 pm |
4:10 – 4:30 pm |
|||||
SL-270 Elizabeth Sobhia Insights from Molecular Dynamics Studies to Combat Isoniazid – Resistant Tuberculosis
|
IL-271 Weihong Song Prenatal Vitamin A Deficiency Facilitates Alzheimer’s Disease Pathogenesis |
IL-272 Nancy L. Parenteau The Rational Biological Design of Regenerative Therapies and Devices
|
SL-273 Hossain Uddin Shekhar Boosting the Food Functionality (In vivo and In vitro) of Spirulina Grown in Bangladesh by Gamma Radiation: An Inspiring Approach |
SL-274 Ngozi Edoh Evaluation of High β-Carotene Cassava Genotypes at Advanced Trial in Nigeria |
|||||
4:50 - 5:10 pm |
5:35 - 5:55 pm |
5:00 - 5:20 pm |
4:20 - 4:40 pm |
4:30 - 4:50 pm |
|||||
SL-275 Namrita Lall Untangling the Opportunities from South African Plants
|
SL-276 Kamil Kuca Synthesis and Biological Evaluation of Novel Tacrine Derivatives and Tacrine-Coumarin Hybrids As Cholinesterase Inhibitors |
SL-277 Xin Wang Neuroprotective Drug Discovery and Neural Stem Cell Research in ALS |
SL-278 Mian Zhou Determine the Role and Mechanism of Gene Codon Usage in Regulating Protein Expression and Folding
|
SL-279 Kazimierz Strzalka Enzymatic De-epoxidation of Violaxanthin and Diadinoxanthin in the Xanthophylls Cycle Requires Presence of Non-bilayer Lipids |
|||||
5:10 – 5:30 pm |
|
5:20 – 5:40 pm |
4:40 – 5:00 pm |
4:50 – 5:10 pm |
|||||
SL-280 Waseem Hassan Evaluation of Secondary Metabolites, Micro-macro Elements and Antimicrobial Activity of Cinnamomum tamala Leaves
|
|
SL-281 Alessia Cedola X-ray Synchrotron Phase Contrast Tomography for the Investigation of Regenerative Treatment in Neurodegenerative Diseases |
SL-282 Mengyi Ren Metallogenic Information Extract and Prognosis Research of Seafloor Polymetallic Sulfide Resources in Southwest Indian Ocean |
SL-283 Li Xu Co-display of Synergetic Rhizopus oryzae Lipase and Candida rugosa Lipase 1 Biodiesel Production |
|||||
5:30 - 5:50 pm |
|
5:40 - 6:00 pm |
5:00 - 5:20 pm |
5:10 - 5:30 pm |
|||||
SL-284 Stephen G. Ward Pharmacological Manipulation of SHIP-1 Modulates Human T Lymphocyte Adhesion and Migration |
|
SL-285 Robert J. Deans Commercializing Adult Stem Cell Therapeutics for Treatment of Stroke and Acute CNS Injury |
SL-286 Menghao Cai Genetically Shaping Morphology of the Filamentous Fungus Aspergillus glaucus for Production of Antitumor Polyketide Aspergiolide A |
SL-287 Pengcheng (Patrick) Fu Synthetic Biology of Cyanobacteria for Bioethanol Production |
|||||
5:50 - 6:10 pm |
|
|
5:20 - 5:40 pm |
5:30 - 5:50 pm |
|||||
SL-288 Syed W.A. Shah Immunomodulatory Potential of Isolated Constituents from Salix Caprea and Simultaneous Quantification, Method Validation of Five Polar Secondary Metabolites by LC/MS |
|
|
SL-289 Vladimir P. Baklaushev Targeted Delivery of Liposomes and Nanoparticles in High Grade Glioma Cells In vitro and In vivo
|
SL-290 Mohamed M. Ibrahim Bio-saline Agriculture of Salicornia begelovii, New Approaches for Biodiesel Production
|
|||||
COFFEE BREAK:
6:00 – 6:45 pm |
|||||||||
DAY 4: Saturday, July 25, 2015 |
||||||||
Chairman:
D.K. Lahiri |
JOINT PLENARY SESSION |
|||||||
Time |
Speakers |
Titles |
||||||
8:30 - 9:20 am |
Ada E. Yonath (Nobel Laureate) PL-291 |
Advanced Therapeutics while Preserving the Microbiome |
||||||
9:20 - 10:10 am |
Edmond J. Yunis PL-292 |
Specific Anti-tuberculin (IgG) High Levels and Lymphocyte In vitro Proliferation with Tuberculin are Better Indicators of LTBI than TST |
||||||
10:10 - 11:00 am |
Richard L. Atkinson PL-293 |
Current Status of Obesity and the Need for a Paradigm Shift |
||||||
POSTER
SESSION & LUNCH BREAK: 11:00 – 1:00 pm |
||||||||
Locations |
Lecture Hall 201 Level 2 |
Lecture Hall 202 Level 2 |
Lecture Hall 203 Level 2 |
Lecture Hall 204 Level 2 |
||||
Tracks |
Drug Delivery & Targeting
|
Innovative Drug Discovery & Nanotechnology / Inflammation and Immunology |
Plant & Environment / Neurodegenerative Disorders |
Pharmaceutical Biotechnology / Other Areas (Nanobiotechnology, bio-safety) / Regenerative Medicine / Industrial & Manufacturing / Academic CRO – Industrial Collaborations in Drug Discovery |
||||
Chairman: V.Weissig Co-Chairman: A.Puri |
Chairman: E.S.Don Co-Chairman: M.C.Vasudev |
Chairman: B.Dewprashad Co-Chairman: J. Rogers |
Chairman: H.H.-C.Siebert Co-Chairman: E.A.R.Rosa |
|||||
1:00 – 1:30 pm |
1:00 – 1:30 pm |
1:00 – 1:20 pm |
1:00 – 1:30 pm |
|||||
IL-294 Volkmar Weissig Specific Delivery of Drugs to Mitochondrial Targets: Manipulating Mitochondrial Functions |
IL-295 Silvia De Paoli Modulatory Effects of Plasma Protein Corona on the Interactions of Nanoparticles with Human Blood Platelets |
SL-296 Surinder Singh Metabolic Engineering of Long Chain Omega-3 Fatty Acids for the Oilseed Industry |
IL-297 Habil H.-C. Siebert New Perspectives in Nanomedicine and Nanopharmacology
|
|||||
1:30 - 2:00 pm |
1:30 - 1:50 pm |
1:20 - 1:40 pm |
1:30 - 2:00 pm |
|||||
IL-298 Anu Puri Phototriggerable Lipid Assemblies and their Applications for Dual Drug Delivery |
SL-299 Stephan T. Stern Generic Nanomedicines: Pharmacokinetic and Bioanalytical Evaluation |
SL-300 Balaji M. Panchal Inhibition of Chilo Partellus (Lepidoptera: Pyralidae) Gut Proteases by Compounds from Ipomoea batata |
IL-301 Tun Liu A Comprehensive Approach to Understand Glycosylation of Monoclonal Antibodies |
|||||
2:00 - 2:20 pm |
1:50 - 2:10 pm |
1:40 - 2:00 pm |
2:00 - 2:20 pm |
|||||
SL-302 Gerard G.M. D’Souza Three Dimensional Cell Culture Models of the Solid Tumor Microenvironment for the Testing of Pharmaceutical Nanocarriers |
SL-303 Marina A. Dobrovolskaia Immunological Properties of Engineered Nanomaterials and Challenges with their Preclinical Characterization |
SL-304 Shree Prakash Panday Plant Stress Adaptation, Signaling and the Regulatory Small RNA Pathways: Evolution and Functional Specialization |
SL-305 Hala A. Amin Whole Cell Biocatalyst for Soyasapogenol B Production from Soybean Saponin |
|||||
2:20 – 2:40 pm |
2:10 – 2:30 pm |
2:00 – 2:20 pm |
2:20 – 2:40 pm |
|||||
SL-306 Aruna Chhikara Co-delivery of Etoposide and Vorinostat Using Poly (Ethylene Glycol) Based Biodegradable Nanogels |
SL-307 Jiwen Zheng Challenges and Considerations in Nano-drug Characterization
|
SL-308 Shifted to SL-119(a) |
SL-309 Bushra H. Kiani Artemisinin Production in Artemisia annua and Artemisia dubia Following Transformation with the Rol ABC Genes and Elucidation of the Sites of its Synthesis |
|||||
2:40 - 3:00 pm |
2:30 - 2:50 pm |
2:20 - 2:40 pm |
2:40 - 3:00 pm |
|||||
SL-310 Josephine S. Modica-Napolitano Treatment Strategies that Enhance the Efficacy and Selectivity of Mitochondria-targeted Anticancer Agents |
SL-311 Gökhan Savaroğlu The Effect of Ultrasound of Amplitute and Expose Time on the Particle Size and Solubility of Naproxene Sodium |
SL-312 Ihuoma Okwuonu Effect of Transgene Copy Number on Vector Backbone (VBB) Integration in Transgenic Cassava Genome |
SL-313 Edvaldo A.R. Rosa Paper-attached Yeast Biofilms. An Alternative for Living Biocatalysts Growth |
|||||
3:00 – 3:20 pm |
2:50 – 3:10 pm |
2:40 – 3:00 pm |
3:00 – 3:20 pm |
|||||
SL- 314 Shana Kelley Mitochondrial Targeting of Therapeutics
|
SL-315 Zhi-Ren Liu Development of Protein Agent Targeting Integrins avb3 at a Novel Site by Rational Protein Design |
SL-316 Benjamin Wolozin Stress Granules and Neurodegeneration: Novel Targets for Therapy in Amyotrophic Laterial Sclerosis and Alzheimer’s Disease |
SL-317 Catherine Michaux Towards a Universal Method for Protein Refolding
|
|||||
3:20 - 3:40 pm |
3:10 - 3:30 pm |
3:00 - 3:20 pm |
3:20 - 3:55 pm |
|||||
SL-318 Mu-Ping Nieh Single-step Formation and Cellular Response of Vesicles and Disk-like Bicelles |
SL-319 Elena S. Don Release-active Antibodies are Innovative Antibodies-based Drugs: New Way to Quality Assessment |
SL-320 Nipun Chopra Role of Neprilysin in Alzheimer’s Disease
|
KNL-321 Ali Khademhosseini Engineered Hydrogels for Regenerative Medicine Applications |
|||||
3:40 - 4:00 pm |
3:30 - 4:00 pm |
3:20 - 3:40 pm |
3:55 - 4:15 pm |
|||||
SL-322 Upal Roy Prolonged Acting Nanomedicine Based Anti-HIV Drug Delivery Targeting Gut Associated Lymphoid Tissues |
IL-323 Thomas J. Webster Advances in Nanotechnology for Drug Delivery
|
SL-324 Debomoy K. Lahiri / Frederic Checler Short Discussion
|
SL-325 Amin A. El-Meligi Nano-Layered Materials for Drug Delivery and Trapping Harmful Anions in Tumor |
|||||
4:00 – 4:20 pm |
4:00 - 4:20 pm |
3:40 – 4:00 pm |
|
|||||
SL-326 Stephan Stern Nano-formulation Modified Drug Pharmacokinetics and Therapy |
SL-326(a) Nicholas Mark Valiante A Medicinal Chemistry Approach to Gaining Pharmacological Control of Immunity |
SL-327 Debomoy K. Lahiri Short Discussion on CAR |
|
|||||
4:20 – 4:40 pm |
4:20 - 4:40 pm |
|
|
|||||
SL-328 Amit Joshi Light Triggered Nanoparticle Theranostics for Cancer
|
SL-328(a) Charles J. Malemud PI3K/Akt/mTOR Signaling: A Potential Target for Inducing Apoptosis in Immune-Mediated Arthritis |
|
|
|||||
4:40 – 5:00 pm |
|
|
|
|||||
SL-329 Shahinaz Shalaby Magnetofection Enhancing Suicidal Gene Therapy of Uterine Fibroid Tumor Cells |
|
|
|
|||||
COFFEE BREAK:
5:00 – 5:30 pm |
||||||||
CASH PRIZE
ANNOUNCEMENT FOR THE BEST POSTER AT 5:30 P.M. (Poster
Presenter’s Presence is Essential to Receive the Cash Award and Certificate
of Merit) PL: Plenary
Lecture ::: KNL: Key Note Lecture ::: IL: Invited Lecture ::: SL: Session
Lecture |
||||||||
TIME
INAUGURAL
PROGRAM
Location:
Ball Room ‘B’ – Level-3
8:30 - 8:35 am
Guests to be Seated
8:35 - 8:45 am
Welcome Remarks by Chairmen Organizing Committee
Prof. Ferid Murad (Nobel Laureate) and Prof. Atta-ur-Rahman, FRS
Chairman: A. Chapel
Co-Chairman: E. Jirillo
JOINT PLENARY SESSION
Location: Ball Room ‘B’ - Level 3
Time
Speakers
Titles
8:45 - 9:35 am
Pamela A. Silver
PL-1
Designing Biology for a Healthy World
9:35 - 10:25 am
Phillip A. Sharp
(Nobel Laureate)
PL-2
MicroRNAs, Small Interfering RNAs and Modular Therapeutics
Locations
Lecture Hall 201
Level 2
Lecture Hall 202
Level 2
Lecture Hall 203
Level 2
Lecture Hall 204
Level 2
Lecture Hall 205
Level 2
Lecture Hall 206
Level 2
Lecture Hall 207
Level 2
Tracks
CNS Drug Discovery & Therapy
Cardiovascular Drug Discovery & Therapy
Cancer Targeted Drug Delivery
Diabetes and Obesity Drug Discovery & Therapy
Regenerative Medicine
Medical Imaging
Other Areas (Food, Protein Expression, Clinical Research) / Business Development
Chairman: W.Wang
Co-Chairman: T.Y. Chang
Chairman: R.A.Khalil
Co-Chairman: A. Hawkridge
Chairman:A.Di Pietro
Co-Chairman:D.S. Dimitrov
Chairman:E.Jirillo
Co-Chairman:F.Z.Basha
Chairman:M.O.Hebb
Co-Chairman: D.Narmoneva
Chairman:Y.Zhou
Co-Chairman:J.Zhang
Chairman:J.X.Ma
Co-Chairman:C.B. Esselstyn
10:30 - 10:50 am
10:30 - 11:00 am
10:30 - 11:05 am
10:30 - 11:00 am
10:30 - 11:00 am
10:30 - 11:00 am
10:30 - 11:00 am
SL-3
Jia Zhou
Development of Serotonin 2C Receptor Positive Allosteric Modulators for Treatment of Neuropsychiatric Diseases
IL-4
Umesh R. Desai
Discovering Antagonists of Glycosaminoglycan-Binding Proteins for Treating Thrombosis, Cancer, and other Diseases
KNL-5
Attilio Di Pietro
Different Strategies to Target Resistant Cancer Cells Overexpressing Multidrug ABC Transporters: Inhibition and Collateral Sensitivity
IL-6
Emilio Jirillo
Childhood Obesity and Nutritional Interventions
IL-7
Tao L. Lowe
Mechanically Tunable and Degradable Hydrogels for Regenerative Medicine
IL-8
Yun Zhou
Quantitative Multimodal Multi-parametric Imaging: Its Integration and Applications
IL-9
JinXia Ma
PSP94, Prostasin and PSP94 to Prostasin Signaling in Cancer
10:50 - 11:10 am
11:00 - 11:20 am
11:05 - 11:40 am
11:00 - 11:30 am
11:00 - 11:30 am
11:00 - 11:20 am
11:00 - 11:20 am
SL- 10
Ta Yuan Chang
ACAT1/SOAT1 as a Therapeutic Target for Alzheimer’s and Other Related Neurodegenerative Diseases
SL-11
Krishna Rajarathnam
Chemokines as Drug Targets for Cardiovascular Diseases
KNL-12
Dimiter S. Dimitrov
Therapeutic Monoclonal Antibodies Against Cancer and Viruses
IL-13
Matteo A. Russo
Role of HIF1α/NFĸB Pathway in Obesity
IL-14
Daria Narmoneva
Vascular Tissue Regeneration: A Biophysical Perspective on the Role of Mechanical, Molecular and Electric Interactions
SL-15
Jianhua Zhang
Comparison of Two Methods for Semiquantitative Evaluation of DaTSCAN
SL-16
Conly Hansen
Production of Hydrogen and Methane from Food Processing Waste in Induced Bed Reactors: Experiment and Modeling
11:10 - 11:30 am
11:20 - 11:40 am
11:40 - 12:00 noon
11:30 - 12:00 noon
11:30 - 11:50 am
11:20 - 11:40 am
11:20 - 11:40 am
SL-17
Rina Aharoni
From Basic Research to Drug Development – The Story of Copaxone in the Treatment of Multiple Sclerosis, Mechanism of Action, and New Applications
SL-18
Robert J. Linhardt
Re-introduction of Bovine Heparin: Regulatory and Compendial Issues
SL-19
Hong-tao Xiao
Anti-tumor Effect of the Newly Synthesized Hydroxychloroquine Conjugate-AHQ
IL-20
Jeffrey I. Mechanick
The Use of Bariatric Surgery in Patients with Diabetes and Obesity
SL-21
Nathaniel Bachrach
Native Extracellular Matrix – A Paradigm for Translatable Regenerative Medicine
SL-22
Xueqi Chen
Multiparametric PET Values in the Prediction of Alzheimer’s Disease Progress
SL-23
Ivana Orlando
Food Science and Biotechnology: Innovative Applications of Non Thermal Technologies in Foods: High Pressure Processing for Increasing the Shelf Life and Sensorial Analysis of Fish and Sea Food
11:30 - 11:50 am
11:40 - 12:00 noon
12:00 - 12:20 pm
12:00 - 12:20 pm
11:50 – 12:10 pm
11:40 - 12:00 noon
11:40 - 12:00 noon
SL-24
Nathali Kaushansky
Novel Immunospecific Therapy with Synthetic Multi-Epitope Targeting Agent Modulate MS-like Disease by Induction of Peripheral Regulatory Mechanisms
SL-25
Masahiro Sakagami
Natural and Synthetic Caffeic Acid-based Oligomers: Anti-oxidative, Anti-e lactase and VEGF Modulatory Activities for Treatment of Emphysema
SL-26
Karli Rosner
A Highly Efficient In-vivo Therapy for Melanoma and Other Cancer Types
SL-27
Lex V. der Ploeg
Deuterated Polyunsaturated Fatty Acids (dPUFAs) Overcome Lipid Peroxidation Damage in CNS Disorders
SL-28
Michael Helmrath
In vivo Model of Human Intestine
SL-29
Rui Gao
Associations Between the Alpha-synuclein Spliced Variants and Monoaminergic Degeneration in Parkinson’s Disease
SL-30
Caldwell B. Esselstyn
Plant-Based Nutrition Adherence Strategy Halts Coronary Disease
11:50 - 12:10 pm
12:00 - 12:20 pm
12:20 - 12:40 pm
12:10 – 12:30 pm
12:00 - 12:20 pm
12:00 - 12:20 pm
SL-31
Amany A. Abdin
Modulatory Effect of Celastrol on Th1/Th2 Cytokines Profile, TLR2 and CD3+ T-lymphocyte Expression in a Relapsing-remitting Model of Multiple Sclerosis in Rats
SL-32
Rinku Majumder
A Novel, Activated Protein C-independent Role of Protein S in Regulating Thrombosis
SL-33
Dror Harats
Vascular Targeting System – A Proprietary Gene Therapy Platform Technology
SL-34
Bruno Doiron
Syner-III: An In vivo Method to Induce Pancreatic Beta Cell Formation in the Adult Pancreas
SL-35
Wang Rong-fu
Application of Parametric Imaging Using 18F-FDG PET/CT Dynamic Multi-bed Scanning in Differential Diagnosis of Pulmonary Lesions
SL-36
Mark Nuijten
Financial Valuation Algorithm for the Assessment of the Futures Sales of a New Innovative Medicinal Product
12:10 – 12:30 pm
SL-37
Stefano Gustincich
SINEUPs: A New Class of Natural and Synthetic Antisense Long Non-coding RNAs that Activate Translation
LUNCH BREAK:
12:30 – 1:30 pm
Locations |
Lecture Hall 201 Level 2 |
Lecture Hall 202 Level 2 |
Lecture Hall 203 Level 2 |
Lecture Hall 204 Level 2 |
Lecture Hall 205 Level 2 |
Lecture Hall 206 Level 2 |
Lecture Hall 207 Level 2 |
Tracks |
Traditional Chinese Medicine / Genomics |
Cardiovascular Drug Discovery & Therapy / Cancer Targeted Drug Delivery |
Enabling Technologies / Pharmacogenomics / Combinatorial Chemistry / Hot Topics in Natural Products / Biologics / Protein and Peptide Sciences |
Diabetes and Obesity Drug Discovery & Therapy / CNS Drug Discovery & Therapy / Process Chemistry & Drug Manufacturing / Inflammation and Immunology Chemistry |
Regenerative Medicine |
Medical Imaging / Medical Biotechnology |
Other Areas (Marine) / Plant & Environment / Pharmaceutical Biotechnology |
Chairman:W.Wang Co-Chairman:W.Chao |
Chairman:C.Perez-Stable Co-Chairman:S.Ali |
Chairman:M. Helmrath Co-Chairman:J.B.Ulmer |
Chairman:F.Z.Basha Co-Chairman:A.Ejaz |
Chairman: T. L. Lowe Co-Chairman:P.Liu |
Chairman:Y.Zhou Co-Chairman:H.-Y.Jiang |
Chairman:R.J.Linhardt Co-Chairman:B.Dewprashad |
|
1:30 - 2:00 pm |
1:30 - 1:50 pm |
1:30 - 2:05 pm |
1:30 - 2:00 pm |
1:30 - 1:50 pm |
1:30 - 1:50 pm |
1:30 - 1:50 pm |
|
IL-38 Wei Wang Chemical, Pharmacological and Quality Control Studies of Traditional Chinese Medicine (TCM) and Ethnic Medicine |
SL-39 Demetrios Braddock The Molecular Basis of Purinergic Signal Metabolism Regulating Hemostasis and Ectopic Calcification |
KNL-40 Jeffrey B. Ulmer New Technologies for Improved Vaccines Against Infectious Diseases and Cancer
|
IL-41 Fatima Z. Basha Design, Discovery and Synthesis of Novel Non-sugar Based α-Glucosidase Inhibitors as Potential Anti-diabetic Agents |
SL-42 Swathi Balaji Scarless Surgery: Are We There Yet?
|
SL-43 Wang Rong-fu Situation and Progress of Tumor Angiogenesis Targeted Imaging and Therapy via Radionuclide Tracing Techniques |
SL-44 Adela Mora-Gutierrez Influence of Bovine and Caprine Milk-Based Peptides on Exopolysaccharide Synthesis by Streptococcus thermophilus and Lactobacillus delbrueckii ssp. Bulgaricus |
|
2:00 – 2:20 pm |
1:50 – 2:10 pm |
2:05 – 2:25 pm |
2:00 – 2:30 pm |
1:50 – 2:10 pm |
1:50 – 2:10 pm |
1:50 – 2:10 pm |
|
SL-45 Xiong Cai A Naturally-derived Immunosuppressive Drug, Rapamycin, Decreases Circulating Tumor Cells in Patients with Lymphangioleiomy-matosis |
SL- 46 Adam Hawkridge Intact Stable Isotope Labeled Plasma Proteins for Multiplexed LC-MS/MS Quantification
|
SL-47 Prasun J. Mishra Advancing Molecular Diagnostics and Precision Medicine Using Non-coding RNA Variants
|
IL-48 Athar Ata Novel Biomedical Agents from Aboriginal Medicinally Important Plants of Canada |
SL-49 Junwang Xu Mesenchymal Stem Cell Treatment Improves Diabetic Wound Healing through Modulation of MicroRNA Expression |
SL-50 Kuangyu Shi Understanding Tracer Diffusion in Tumor Tissue for Hypoxia Imaging Using Reaction-diffusion Modeling: Matching Computational Simulation to Dynamic [18F]FMISO PET Measurements in Tumors |
SL-51 Patricia A. Sobecky Microbial Response(s) to the 2010 Deepwater Horizon Gulf Oil Spill: a 5-year Study of a Coastal Alabama Salt Marsh |
2:20 - 2:40 pm |
2:10 - 2:45 pm |
2:25 - 2:45 pm |
2:30 - 2:50 pm |
2:10 - 2:30 pm |
2:10 - 2:30 pm |
2:10 - 2:40 pm |
SL-52 Jing Shen Effect of Moxibustion on T Lymphocyte Subsets of Helicobacter pylori-associated Gastritis Rats |
KNL-53 Gautam Chaudhuri Cancer Cells and ATP Generation: Beyond Warburg |
SL-54 Nesterov-Müller Alexander Novel High Density Peptide Arrays with Combinatorial Deposition of Amino Acid Particles for Antibody Profiling |
SL-55 Asma Ejaz Betaine Supplementation Improves Systemic Metabolism and Glycemia in HFD-Fed Mice
|
SL-56 Matthew O. Hebb Autologous Brain Sources for Personalized Cell Therapy in Neurological Disease
|
SL-57 Hong-Yu Jiang Protective Effects of Low Doses Radiation Against Doxorubicin-induced Cardiac Toxicity in Balb/C Mices |
IL-58 Brahmadeo Dewprashad Medicinal Plants Used by Immigrants from the Caribbean
|
2:40 - 3:00 pm |
2:45 - 3:20 pm |
2:45 - 3:05 pm |
2:50 - 3:20 pm |
2:30 - 2:50 pm |
2:30 - 2:50 pm |
2:40 - 3:00 pm |
SL-59 Zhiying Huang Toxicological Finding in Beagle Dogs After a Single or 4 Weeks Oral Gavage of Triptolide |
KNL-60 Rakesh Kumar Targeting MTA1 Master Chromatin Remodeler in Cancer and Stem Cell Biology
|
SL-61 Anita Abedi Novel Platinum Complexes [Pt(N-N)C14], as Suggested Anticancer Drugs |
IL-62 Zhi-Gang Jiang Co-supression of Intracellular Calcium and Oxidative Stress, A Key Strategy for Development of Neuroprotective Drugs |
SL-63 Philip Liu Tracking Regeneration of the Brain After Gene Therapy Using Targeted Guided MRI
|
SL-64 Dalila Naimi Assessment of Crude Extract of Helix Aspersa on Chemo-induced Colitis in Rat |
SL-65 Shin-ichi Kayano Antioxidant Properties of Prunes (Prunus domestica L.) and their Constituents |
3:00 – 3:20 pm |
3:20 – 3:50 pm |
3:05 – 3:25 pm |
3:20 – 3:40 pm |
2:50 – 3:10 pm |
2:50 – 3:10 pm |
3:00 – 3:20 pm |
SL-66 Rui Li The Metabolic and Pharmacokinetic Analysis of Curcuminoids Based on Nanoparticle Formulations by Liquid Chromatography Coupled with Tandem Mass Spectrometry |
IL-67 Carlos Perez-Stable Prostate Cancer-Specific Destruction of Androgen Receptor with Deubiquitinase Inhibitors |
SL-68 Daniel Appella Combionatorial Multivalent Display Using a Synthetic, PNA-based Scaffold to Characterize Ligand-receptor Interactions
|
SL-69 Akila Ramanathan Development of Circadian Rhythm Based Formulation of Atomoxetine Hydrochloride for the Treatment of Attention Deficit Hyperactivity Disorder
|
SL-70 Jian Yang Biodegradable Photoluminescent Polymers and Molecules for Tissue Engineering, Drug Delivery, and Imaging |
SL-71 Hala F.M. Kamel Evaluation of Advanced Glycation end Products (AGEs), Circulating Soluble Receptor for Advanced Glycation End Products (sRAGE) and Oxidized Low-density Lipoproteins (OxLDL) in Hemodialysis Patients |
SL-72 Herry Utomo Biotechnological Approach to Increasing Nutritional Quality in High Yielding Rice
|
3:20 - 3:40 pm |
3:50 - 4:10 pm |
3:25 - 3:45 pm |
3:40 - 4:00 pm |
3:10 - 3:30 pm |
3:10 - 3:30 pm |
3:20 - 3:40 pm |
SL-73 Xue-Fei Tian Study on Anti-Lung Cancer Efficiency of Centipede Extraction In vitro and in vivo |
SL-74 Kirk J. McManus Synthetic Lethal Targeting of Colorectal Cancer Cells through SOD1 Inhibition |
SL-75 M. Younus Rana Residues of Enrofloxacin in Tissues of Freshly Slaughtered Broiler Chickens Available in Local Market of Jhang City (Pakistan) |
SL-76 Kinga Salat Solute Carrier 6A1 (SLC6A1; GAT1) Transporter Subfamily as a Target for Novel Memory Enhancing Drugs
|
SL-77 Shanfeng Wang Injectable and Biodegradable Polymeric Biomaterials for Regenerative Medicine |
SL-78 Sin H. Lee Bring Sanger Sequencing to the Community Clinical Laboratories Worldwide
|
SL-79 Ida Wenefrida Nutritional Quality Enhancement in a Non-GMO High Yielding Rice |
3:40 – 4:00 pm |
4:10 – 4:30 pm |
3:45 – 4:20 pm |
4:00 – 4:20 pm |
3:30 – 3:50 pm |
3:30 – 3:50 pm |
3:40 – 4:00 pm |
SL-80 Wei Li 3D Quality Control of Entire Molecule Complex of Compound Danshen Dripping Pills |
SL-81 Yoko Matsumoto Novel Liposomes Including Trehalose Surfactant Inhibit the Growth of Tumor Cells along with Apoptosis |
KNL-82 Muhammad Iqbal Choudhary Nature-based Drug Discovery – Reemerging Paradigm
|
SL-83 Shyama D. Patel Hypoxia Ischemia in the Neonatal Rat: Therapeutic Hypothermia and Mast Cell Stabilization as Adjunct Pharmacotherapy |
SL-84 Abdul Q. Sheikh Novel Smooth Muscle Cell Progenitors are Primed to Muscularize in Disease |
SL-85 Ekram W. Abd El-Wahab Specific Recognition of the HIV-1 Genomic RNA by the Gag Precursor |
SL-86 Krisztina Szabo The First Extensive Case-study on the Effects of Artificial Mycorrhization of Acer buergerianum Miq. in Hungary |
4:00 - 4:20 pm |
4:30 - 4:50 pm |
4:20 - 4:40 pm |
4:20 - 4:40 pm |
3:50 - 4:10 pm |
3:50 - 4:10 pm |
4:00 - 4:35 pm |
SL-87 Liu Mi Effects of Electroacupuncture on the Ultrastructure of ICC and Expression of Protein CX43 in FD Rats
|
SL-88 James Cleary Overview of the Current and Future Role of Immune Checkpoint Blockade in Oncology
|
SL-89 Adebola O. Oyedeji Anticancer, Antioxidant and Antimicrobial Activities of Some Synthesized Ursolic Acid Derivatives
|
SL-90 Yasuo Iwadate Logical Refinement of Therapeutic Targets for Glioblastoma Based on Multidisciplinary Proteomic Approaches |
SL-91 Mohamed H. Doweidar Numerical Modeling of Mechanotactic Influence on Cell Morphology
|
SL-92 Wei Li Blocking the Function of Inflammatory Cytokines and Mediators by Using IL-10 and TGF-β: A Potential Biological Immunotherapy for Intervertebral Disc Degeneration in a Beagle Model |
KNL-93 Robert J. Linhardt Synthetic and Bioengineered Heparin-based Therapeutics |
4:20 - 4:40 pm |
4:50 - 5:10 pm |
4:40 - 5:00 pm |
4:40 - 5:00 pm |
4:10 - 4:30 pm |
4:10 - 4:30 pm |
4:35 - 4:55 pm |
SL-94 Wang Chao Influence of Electroacupuncture Pretreatment on Serum NO and NOS and Myocardial Ultrastructures in Myocardial Ischemia and Reperfusion Injury
|
SL-95 Darrell R. Borger Multifaceted Approach to Cancer Biomarker Discovery in a Clinical Setting |
SL-96 G.J. Sharma Evaluation of Antioxidant Potentials and Radioprotective Properties of Tropical Ginger in Albino Rats
|
SL-97 Jian-Dong Li Negative Feedback Regulation of Inflammation& Novel Anti-Inflammatory Strategy
|
SL-98 Sandeep Soni Initial Results of Gene Therapy for β-Thalassemia Major via Transplantation of Autologous Hematopoietic Stem Cells Transduced Ex-vivo with a Lentiviral βA-T87Q-Globin Vector |
SL-99 Sarman Singh Application of Newer Molecular Methods for Diagnosing and Drug Resistance Detection in Mycobacterium tuberculosis: Evaluation in Indian Setting |
SL-100 Uttmakumar S. Bagde In vitro Proliferative Effect of Aloe Vera Extracts on Hair Follicles Isolated from the Alopecia Areta Patch |
4:40 – 5:00 pm |
5:10 – 5:30 pm |
5:00 – 5:20 pm |
5:00 – 5:20 pm |
4:30 – 4:50 pm |
4:30 – 4:50 pm |
4:55 – 5:15 pm |
SL-101 Mei-lin Liu Effect of Shenyuan on Anti-inflammatory and Hemodynamic Factors in a Porcine Model of Acute Myocardial Infarction |
SL-102 Nenggang Zhang Sepin-1, A Novel Separase Inhibitor, for Breast Cancer Therapy |
SL-103 Santosh K. Singh Antibacterial Activity and Preliminary Phytochemical Screening of Endophytic Fungal Extract of Rauvolfia serpentina
|
SL-104 Phuong T. Le Direct Arylation and its Application on Scale to the Synthesis of PF-06463922, A Macrocyclic Inhibitor of ALK/ROS1
|
SL-105 David Naor Anti-inflammatory Regenerative Activity of a CD44-derived Peptide |
SL-106 Hongjun Yang Photocross Linkable Maleic Anhydride Acylated Chitosan/Methacryl Poly (Vinyl Alcohol) Nanofibrous Membrane as Potential Wound Dressing for Skin Regeneration |
SL-107 Ella L. Kim The Role of Stem-like Glioma Cells in GBM Progression and Post-treatment Recurrence |
5:00 - 5:20 pm |
5:30 - 5:50 pm |
5:20 - 5:40 pm |
5:20 - 5:40 pm |
4:50 - 5:10 pm |
4:50 - 5:10 pm |
5:15 - 5:35 pm |
SL-108 Meilin Liu Identification of Aspirin Response Related Gene Profiles in the Elderly Population with Coronary Artery Disease |
SL-109 Matthew O. Hebb Intratumoral Modulation Therapy for Glioblastoma |
SL-110 Cid A.M. Santos Uleine
|
SL-111 Jun-ichi Kadokawa Enzymatic Synthesis of Protein-mimic Polysaccharides as Candidate for New Biomedical Materials |
SL-112 Ashim K. Mitra Novel Therapeutic Strategies for Delivering Therapeutics to Brain – Circumventing the Efflux and Permeability Barriers |
SL-113 Huseyin A. Balcioglu Temporomandibular Joint Disorders, Biotechnology and Evolving Trends
|
SL-114 Jaeho Lee Effects of Strong Acid and Ionic Materials on Microwave-assisted Thermo-chemical Hydrolysis of Cattle Manure
|
|
5:50 - 6:10 pm |
5:40 - 6:00 pm |
5:40 - 6:00 pm |
5:10 - 5:30 pm |
5:10 - 5:30 pm |
5:35 - 5:55 pm |
|
SL-115 Cody P. Coyne Synthesis of Covalent Biochemotherapeu-tics with Properties of Selectively “Targeted” Anti-neoplastic Cytotoxicity |
SL-116 Jose C. Martins Understanding Biological Activity and Self-assembly of Antimicrobial Cyclic Lipodepsipeptide Using a Molecular Approach |
SL-117 Michel Baltas Bisvanillin and Bis Aryl Ether Scaffolds for Elaboration of Antiatherogenic Agents; Synthesis and Biological Activities |
SL-118 Somaya Hosny Potential Therapeutic Effect of Hematopoietic Stem Cells on Cerebellar Ataxia in Adult Female Rats Subjected to Cerebellar Damage by Monosodium Glutamate |
SL-119 Nilufer Balcioglu Finite Element Analysis in Oral Implantology |
SL-119(a) Im-Gyu Byun Variation of Algae Occurrence Before and After Weir Construction at Mulgeum Site in Downstream the Nakdong River, South Korea |
|
|
|
|
5:30 - 5:50 pm |
5:30 - 5:50 pm |
|
|
|
|
|
SL-120 Qiaobing Xu Nanoparticles for Neural Regeneration |
SL-121 Amanda Arnold Convergence: A Transformative Approach to Advanced Research at the Intersection of the Life Physical and Engineering Sciences |
|
COFFEE BREAK:
6:00 – 6:45 pm |
DAY 2: Thursday, July 23, 2015 |
||||||||||||||
Chairman: C. N. Serhan |
JOINT PLENARY SESSION |
|||||||||||||
Time |
Speakers |
Titles |
||||||||||||
8:30 - 9:20 am |
Ferid Murad (Nobel Laureate) PL-122 |
Application of Nitric Oxide Research to Drug Development |
||||||||||||
9:20 - 10:10 am |
Martin Nowak PL-123 |
Evolutionary Dynamics and Treatment of Cancer |
||||||||||||
Locations |
Lecture Hall 201 Level 2 |
Lecture Hall 202 Level 2 |
Lecture Hall 203 Level 2 |
Lecture Hall 204 Level 2 |
Lecture Hall 205 Level 2 |
Lecture Hall 206 Level 2 |
||||||||
Tracks |
Drug Discovery in Preclinical Research
|
Cardiovascular Drug Discovery & Therapy |
Innovative Drug Discovery & Nanotechnology |
In Silico Drug Design & In Silico Screening |
Regenerative Medicine |
Pharmaceutical Biotechnology |
||||||||
Chairman: W.B.Weglicki Co-Chairman: S. Neumann |
Chairman: R.A.Khalil Co-Chairman: R.J.Linhardt |
Chairman: S.De Paoli Co-Chairman: E.S.Don |
Chairman: J.Skolnick Co-Chairman: M.Shalaeva |
Chairman: A.Q.Ye Co-Chairman: W.J. Rowe |
Chairman: R.S.Ferreira Co-Chairman: M.Cai |
|||||||||
10:20 - 10:50 am |
10:20 - 10:50 am |
10:20 - 10:50 am |
10:20 - 10:55 am |
10:20 - 10:50 am |
10:20 - 10:50 am |
|||||||||
IL-124 Eugene L.P. Chekler Tissue Selective Androgen Receptor Modulators (SARMs): A Path to a Clinical Candidate
|
IL-125 Raouf A. Khalil Role of Microvascular Endothelial Type B Endothelin Receptor During Pregnancy Implications in Hypertensive Pregnancy and Preclampsia |
IL-126 Jean-Pierre Leburton Genomics with Graphene Nanotechnology
|
KNL-127 Jeffrey Skolnick On the Origin and Completeness of Ligand Binding Pockets with Applications to Drug Discovery
|
IL-128 Adam Q. Ye Controlled Released Scaffolding Biomaterial for Bone Tissue Engineering: A Novel Therapeutic Strategy for Clefts Patients
|
IL-129 Alain Chapel Stem Cell Therapy for the Treatment of Severe Tissue Damage after Radiation Exposure |
|||||||||
10:50 - 11:20 am |
10:50 - 11:10 am |
10:50 - 11:10 am |
10:55 - 11:25 am |
10:50 - 11:20 am |
10:50 - 11:10 am |
|||||||||
IL-130 Tove Tuntland Target Based vs. Phenotypic Screening Approaches in Drug Discovery |
SL-131 Ruomei Qi Ginkgolide B Reduces TLR4 and Inflammatory Protein Expression in Glucose-Treated HUVECs
|
SL-132 Rashid Bashir Nanopore-Based Detection of Biomarkers for Cancer Diagnostics
|
IL-133 Marina Shalaeva Useful Descriptors in Beyond Rule-of-Five Drug Design Space?
|
IL-134 William J. Rowe The Neil Armstrong Space Syndrome
|
SL-135 Rasha F. Mady The Evaluation of Cercarial Transformation Fluid Used Singly and in Combination with Curde Cercarial Antigen in Experimental Schistosomiasis mansoni |
|||||||||
11:20 - 11:40 am |
11:10 - 11:30 am |
11:10 - 11:30 am |
11:25 - 11:45 am |
11:20 - 11:50 am |
11:10 - 11:30 am |
|||||||||
SL-136 Joerg Eder Discovery of First-in-class Drugs: Target- and Systems-based Approaches
|
SL-137 Jan Torzewski Inhibiting C-reactive Protein for the Treatment of Cardiovascular Disease – Way into Clinical Studies |
SL-138 Marija Drndic Biomolecule Analysis and DNA Sequencing with Solid-state Nanopores |
SL-139 Hua Gao Integration of In Silico Prediction in Drug Discovery Process
|
IL-140 Jeffrey Harrison Personalized Healthcare: from Research to Reality
|
SL-141 Fuad Fares Long Acting Analogs of Glycoprotein Hormones Designed by Site-directed Mutagenesis and Gene Fusion |
|||||||||
11:40 - 12:00 noon |
11:30 - 11:50 am |
11:30 - 11:50 am |
11:45 - 12:05 pm |
11:50 - 12:10 pm |
11:30 - 11:50 am |
|||||||||
SL-142 Peter Wookey Targeting Calcitonin Receptor Expressed by Brain Tumour Initiating Cells of Glioblastoma Multiforme |
SL-143 Martin Safo Rationally Designed Allosteric Effectors of Hemoglobin Exhibit Superior Antisickling Properties |
SL-144 Michael A. Stroscio Nanotechnology-based Tools for the Study of the Affinity and Selectivity of Antigens for Small Molecular Targets Underlying Drug Discovery and Therapeutics |
SL-145 Franco Lombardo Computational Approaches to PK-Friendly (Drug-like) Molecules
|
SL-146 Bogdan M. Wozniewicz Human Thymus Derived Progenitor/Stem Cells Immunotherapy in Autoimmune Diseases
|
SL-147 Gloria N. Okwu Hypolipidemic and Hypoglycemic Activities of Ethanol Extract of Cyperus rotundus Rhizome |
|||||||||
12:00 - 12:20 pm |
11:50 - 12:10 pm |
11:50 - 12:10 pm |
12:05 - 12:25 pm |
12:10 - 12:30 pm |
11:50 - 12:10 pm |
|||||||||
SL-148 Alexey Rak The Use of Microscale Thermophoresis, Virtual Screening and Thermal Shift Assays for the Rapid Identification of Fragments Active Against Human Kinase |
SL-149 Jian Liu Chemoenzymatic Synthesis of Low Molecular Weight Heparins |
SL-150 Milana C. Vasudev Peptide Nanotubes for the Non-invasive Detection of Biomolecule Secretion from Cells |
SL-151 Oleg Reva Similarity and Difference in Mechanisms of Action of Antistaphylococcal Antibiotics Mupirocin and Batumin Revealed by in Silico Molecular Docking |
SL-152 Marianne Ellis Scale-up of Immune Cell Therapies for Organ Transplants
|
SL-153 Chetana Roat Endophytic Fungus as a Source of Bioactive Secondary Metabolites: Resveratrol and Viniferin
|
|||||||||
12:20 - 12:40 pm |
12:10 - 12:30 pm |
12:10 - 12:30 pm |
|
|
12:10 - 12:30 pm |
|||||||||
SL-154 Lexie S. Holliday Rational Identification of Enoxacin as a Novel V-ATPase (and/or MicroRNA?)-directed Osteoclast Inhibitor |
SL-155 Agnes Azimzadeh Synthetic Heparan Sulfate Mimetics as Novel Anticoagulants: In vitro Evaluation for Xenotransplantation |
SL-156 Georgeta Crivat Nanoparticle Based Sensors with Biological Applications
|
|
|
SL-157 Rui S. Ferreira Junior Molecule Drug Candidates – Prospecting, Development, Optimization and Clinical Trials: Two Brazilian Successful Cases |
|||||||||
LUNCH BREAK:
12:30 – 2:00 pm |
||||||||||||||
Locations |
Lecture Hall 201 Level 2 |
Lecture Hall 202 Level 2 |
Lecture Hall 203 Level 2 |
Lecture Hall 204 Level 2 |
Lecture Hall 205 Level 2 |
Lecture Hall 206 Level 2 |
||||||||
Tracks |
Drug Discovery in Preclinical Research |
Stereoselective Synthesis of Bioactive Compounds / Inflammation and Immunology / Translational Medicine / Biologics |
Bioactive Lipids / High Throughput Screening & Laboratory Automation / Medical Imaging / Drug Metabolism / Hot Topics in Drug Targets / Proteomics & Bioinformatics |
In Silico Drug Design & In Silico Screening/ Academic CRO – Industrial Collaborations in Drug Discovery / Recent Advances in Patient Treatment & Care
|
Plant & Environment |
Pharmaceutical Biotechnology
|
||||||||
Chairman: T.Tuntland Co-Chairman: E.L.P.Chekler |
Chairman: S. Premawansa Co-Chairman: S.Ari |
Chairman: M.Linder Co-Chairman: W.A. Zaghary |
Chairman: E.P. Hoffman Co-Chairman: T.D.Y.Chung |
Chairman: Q. Liu Co-Chairman: L.Ji |
Chairman: N.L.Parenteau Co-Chairman: Y.J.Rosenberg |
|||||||||
2:00 - 2:35 pm |
2:00 - 2:20 pm |
2:00 - 2:20 pm |
2:00 - 2:20 pm |
2:00 - 2:30 pm |
2:00 - 2:35 pm |
|||||||||
KNL-158 William B. Weglicki Prevention of EGFR-Tyrosine Kinase Inhibitor Complications by Treatment with NK-1 Receptor Blockade |
SL-159 Xiang Liu Total Synthesis of 6-Deoxypladienolide D and Assessment of Splicing Inhibitory Activity in a Mutant SF3B1 Cancer Cell Line |
SL-160 Messaouda Kaci Nanoencaosulation of Coenzyme Q10 by a New Emulsification Process Used in Cosmetic |
SL-161 Mustafa Guzel Novel Drug Canditates for Type-2 Diabetes Mellitus (T2DM): From Bench to Bedside |
IL-162 Qing Liu Characterization of an Exceptionally Large FAD2 Gene Family and Development of Super High Oleic Genotype in Safflower |
KNL-163 Muhammad I. Choudhary Creating Bioactive Chemical Space by Biotransformation |
|||||||||
2:35 - 3:05 pm |
2:20 - 2:50 pm |
2:20 - 2:40 pm |
2:20 - 2:55 pm |
2:30 - 2:50 pm |
2:35 - 3:05 pm |
|||||||||
IL-164 Jetze J. Tepe Expanding Chemical Space Beyond Drugability-rules: The Search for Mechanistically Distinct Proteasome Inhibitors |
IL-165 Sunil Premawansa Nitrogen and Oxygen Intermediates and Antibody Mediated Platelet Cytotoxicity as Prognostic Markers for Dengue Severity |
SL-166 Michel Linder Morphological and Biophysical Properties of Natural Phospholipidsbased Biomembranes |
KNL-167 Eric P. Hoffman VBP15 for DMD: A Collaborative Public/Private Partnership Enabled by Venture Philanthropy Support from the International Stake-holder Community |
SL-168 Steve Jobling The Role of Cellulose-synthase-like CsIF6 in 1,3;1,4-β-D-glucan Biosynthesis and Overexpression in Wheat Grain to Increase Soluble Dietary Fiber Levels |
IL-169 Anton Buzdin Novel Approach for Big Data Management at the Level of Intracellular Signalization and its Applications to Biomedicine, Drug Discovery and Personalized Therapy |
|||||||||
3:05 – 3:35 pm |
2:50 – 3:10 pm |
2:40 – 3:00 pm |
2:55 – 3:25 pm |
2:50 – 3:10 pm |
3:05 – 3:25 pm |
|||||||||
IL-170 Susanne Neumann Small-molecule “drug-like” TSH Receptor Agonists and Antagonists |
SL-171 Abu Salim Mustafa Immune Responses to Candidate Vaccine Antigens Delivered through Naked Plasmids and Mycobacterial Vectors |
SL-172 Nitish Agrawal Development of Novel Class of M1 ERAP Aminopeptidase Inhibitors for Treating Autoimmune Diseases
|
IL-173 Thomas D.Y. Chung Open Innovation in Drug Discovery & Translational Research in Academia
|
SL-174 Zachary Demorest Highly Efficient Genome Editing for Crop Improvement
|
SL-175 Yvonne J. Rosenberg Pharmacokinetics and Immunogenicity of Plant-derived Broadly Neutralizing HIV Monoclonal Antibodies in Macaques |
|||||||||
3:35 - 3:55 pm |
3:10 - 3:30 pm |
3:00 - 3:20 pm |
3:25 - 3:45 pm |
3:10 - 3:30 pm |
3:25 - 3:45 pm |
|||||||||
SL-176 Henry Yu Discovery of Orally Active FSHR Allosteric Modulators
|
SL-177 Chanika D. Jayasinghe In vivo and In vitro Immunostimulatory Activity of Sri Lankan Wild Type Carica Papaya L. Mature Leaf Concentrate in Rats |
SL-178 Liqin Du Identifying Novel Differentiation Agents for Neuroblastoma Therapy |
SL-179 Andrew D. Badley New Frameworks for Translational Research at the Mayo Clinic: Center for Clinical & Translational Sciences (CCATS) |
SL-180 Rachel Amir Evidence of Metabolic Competition between Methionine and Glutathione Biosynthetic Pathways |
SL-181 Alexei Yeliseev Human Cannabionoid Receptor CB2: Expression, Functional and Structural Studies
|
|||||||||
3:55 – 4:15 pm |
3:30 – 3:50 pm |
3:20 – 3:40 pm |
3:45 - 4:05 pm |
3:30 – 3:50 pm |
3:45 – 4:05 pm |
|||||||||
SL-182 Zaneta Nikolovska-Coleska Discovery and Development of Small Molecule Modulators of Apoptosis as New Anticancer Drugs
|
SL-183 Agnes M. Azimzadeh Targeting Immune Costimulation Using a Novel αCD28 Peggylated Fab and CD154 Blockade: Efficacy in a Pre-Clinical Transplant Model |
SL-184 Sulei Zhang First Multi-site Study on Quantitative Dynamic Whole-body FDG PET-CT in Oncologic Imaging |
SL-185 Ralph J. Garippa Friends with Benefits: Why Partnering with an Academic CRO Makes Ultimate Sense
|
SL-186 Abed A.M. J. Almanssoori RAPD-PCR Analysis of Indigenous Iraqi Sinorhizobium meliloti Isolates Differing in their Ability to Drought Tolerance |
SL-187 Shi Jiancheng MTDLs Design on Acetylcholinesterase (AChE) and β-secretase (BACE-1): 3D-QSAR and Molecular Docking Studies Globin Vector |
|||||||||
4:15 - 4:35 pm |
3:50 - 4:10 pm |
3:40 - 4:00 pm |
4:05 - 4:25 pm |
3:50 - 4:10 pm |
4:05 - 4:25 pm |
|||||||||
SL-188 Hiroshi Nagase Design and Synthesis of Novel δ Opioid Agonists and their Pharmacologies
|
SL-189 Madhu Chopra Synergistic Effect of HDAC Inhibitor (Panobinostat) and Topoisomerase Inhibitors on Cervical Cancer Cells |
SL-190 Wafaa A. Zaghary Preliminary Assessment on 99mTc-salmeterol Xinafoate as a Potential Bone-imaging Agent |
SL-191 Edward Kahn When Open Innovation Meets Repurposing
|
SL-192 Rachel A. Burton The Deconstruction of Seed Mucilages
|
SL-193 Chong K. Phin Antibacterial Activity, Mechanism of Action and Phytochemical Studies of Cynodon Dactylon (L.) Pers. Solid Phase Extract (SPE) Against Some Bacterial Pathogens |
|||||||||
4:35 – 4:55 pm |
4:10 – 4:30 pm |
4:00 – 4:30 pm |
4:25 – 4:45 pm |
4:10 – 4:30 pm |
4:25 – 4:45 pm |
|||||||||
SL-194 Edward Holson Development of a β-arrestin Biased D2R Antagonist for the Treatment of Schizophrenia |
SL-195 Thomas Herz A Full-360-Translational Pharmacology Concept – From Pre-Clinical Experiments to Clinical Data and Back |
IL-196 Esmaiel Jabbari Synthesis of Hydrolysable Nanogels for Controlled Temporal Delivery of Vasculogenic Factors in Patterned Cellular Constructs |
SL-197 Stephen Freedman Exploring New Ideas for the Academic Industry Interface
|
SL-198 Lianghui Ji A Whole Plant Approach for Nitrogen-fixation in Non-leguminous Crops
|
SL-199 Rachel G. Lichtenstein Inhibition of the IgG-FcγRIIIA Interactions in mSOD1 Mice Prolonging Mouse Survival |
|||||||||
4:55 - 5:15 pm |
4:30 - 4:50 pm |
4:30 - 4:50 pm |
4:45 - 5:05 pm |
4:30 - 4:50 pm |
4:45 - 5:05 pm |
|||||||||
SL-200 Daniel Appella Targeting HIV Nucleocapsid Protein via a Small Molecule Platform and Related Preclinical Development
|
SL-201 Jamal Zidan Vascular Endothelial Growth Factor Expression Compared to Clinical and Pathological Features in Ovarian Cancer |
SL-202 Divya Samineni Use of Physiologically-based Pharmacokinetic (Pbpk) Modeling to Assess Drug Interaction Potential of Antibody-drug Conjugates (Adcs) |
SL-203 Oluwatoyin A. Odeku Formulation of Floating Gastroretentive Metronidazole Microspheres Using Cassava Starch (Manihot Esculenta) as Polymer
|
SL-204 Joanna D. Mankiewicz-Boczek Increasing the Efficiency of Nitrogen Compounds Removal from Agricultural Areas through the Optimization of Conditions for Microbial Activity |
SL-205 Tian Wang The Development of a High Resolution LC-MS Peptide Mapping Method for Automated Quantification of N-linked Glycans in Immunoglobulins |
|||||||||
5:15 – 5:35 pm |
4:50 – 5:10 pm |
4:50 – 5:10 pm |
5:05 – 5:25 pm |
4:50 – 5:10 pm |
5:05 – 5:25 pm |
|||||||||
SL-206 Jia Zhou Developing Small-molecule Bax Activators for Cancer Therapy |
SL-207 Mehrdad Modaresi Effect of Althaea officinalis L. Root Extract on Concentration of Blood Proteins in Mice
|
SL-208 Keltoum Anflous-Pharayra VDACs Deficient Mice: An Original Model to Target Selectivity Metastasis
|
SL-209 Ke Cheng Development of a Cloud-based Histology Database for Collaborative Cancer Research |
SL-210 Rainer Fischer Plant-Based Biopharmaceuticals for Emergency Responses and Alternative Rapid Production of Novel Biopharmaceuticals |
SL-211 Smail Meziani PAOT Technology® New Approach for Determination of Oxidative Stress Status of Biological Liquids and Tissues |
|||||||||
5:35 - 5:55 pm |
5:10 - 5:30 pm |
5:10 - 5:30 pm |
5:25 - 5:45 pm |
5:10 - 5:30 pm |
5:25 - 5:45 pm |
|||||||||
SL-212 Andres E. Dulcey Discovery, Optimization, and Characterization of Novel Chlorcyclizine Derivatives for the Treatment of Hepatitis C Virus Infection
|
SL-213 Sule Ari Bioactive Properties of Turkish Endemic Astragalus chrysochlorus |
SL-214 Mehmet E. Buyukbingol 3D Analysis of the Binding Sites for Predicting Binding Affinities in Drug Design |
SL-215 Jennifer Smith ICCB-Longwood: Examples of How an Academic Screening Core can Enable Industry Collaborations |
SL-216 Jamshid Jazestani Harnessing Microbial Interaction for Increasing Crop Productivity in Semiarid Prairie Agricultural Region of Western Canada |
SL-217 Jun Shao Non-invasive Delivery of Biotechnological Drugs |
|||||||||
5:55 - 6:15 pm |
5:30 - 5:50 pm |
5:30 - 5:50 pm |
5:45 - 6:05 pm |
5:30 - 5:50 pm |
|
|||||||||
SL-217(a) Jerrie S. Refuerzo NanoscaleDrug Carrying Systems to Prevent Placemental Passage of Harmful Drugs to the Fetus in a Pregnant Rodent Model
|
SL-218 Sadhna Sharma In Silico Identification of Promiscuous CTL Epitopes of mymA Operation Protains of Mycobacterium tuberculosis for a Epitope Based Vaccine Design |
SL-219 Elie Hadchity Kruppel Like Factors and Heat Shock Protein 27: New Potential Markers of Larynx and Lung Carcinomas |
SL-220 Almeriane M. Weffort-Santos Uleine, A Booster of the Immune Response: Activity on AIDS Patients |
SL-221 Rasha F. Mady Microsporidia and Zingiber officinale (Ginger); an Emerging Parasite and an Old Medicinal Plants: In vivo Trial |
|
|||||||||
COFFEE BREAK:
6:00 – 6:45 pm |
||||||||||||||
DAY 3: Friday, July 24, 2015 |
|||||||||
Chairman:
Atta-ur-Rahman |
JOINT PLENARY SESSION |
||||||||
Time |
Speakers |
Titles |
|||||||
8:30 - 9:20 am |
Bernhard O. Palsson PL-222 |
Reconstruction, Modeling and Use of Genome-scale Networks in Biology |
|||||||
9:20 - 10:10 am |
Charles N. Serhan PL-223 |
Novel Pro-resolving Lipid Mediators in Inflammation & Infection Leads for Resolution Physiology and Pharmacology |
|||||||
10:10 - 11:00 am |
Shuji Ogino PL-224 |
Emerging Pharmaco-MPE (Molecular Pathological Epidemiology) Paradigm for Global Precision Medicine |
|||||||
POSTER
SESSION & LUNCH BREAK: 11:00 – 1:00 pm |
|||||||||
Locations |
Lecture Hall 201 Level 2 |
Lecture Hall 202 Level 2 |
Lecture Hall 203 Level 2 |
Lecture Hall 204 Level 2 |
Lecture Hall 205 Level 2 |
||||
Tracks |
Anti-Infectives / Pharmaceutical Research & Development / Nutraceutical Drug Discovery & Therapy / Inflammation and Immunology / Chemistry |
Neurodegenerative Disorders / CNS Drug Discovery & Therapy |
Hot Topics in Medicinal Chemistry / Regenerative Medicine |
Medical Biotechnology / Pharmaceutical Biotechnology / Other Areas (Microrobot, Food, Protein Expression, Nanobiotechnology, Marine, Systems Biology) / Marine Biotechnology |
Plant & Environment / Industrial & Manufacturing |
||||
Chairman: M.G.Moloney Co-Chairman: R.Chaguturu |
Chairman: D.K.Lahiri Co-Chairman: F.Checler |
Chairman: C.McInnes Co-Chairman:D.S.Rawat |
Chairman: H.U.Shekhar Co-Chairman: K.Saito |
Chairman: I.J.Diaz-Maroto Co-Chairman: P. (Patrick) Fu |
|||||
1:00 – 1:35 pm |
1:00 – 1:35 pm |
1:00 – 1:30 pm |
1:00 – 1:20 pm |
1:00 – 1:30 pm |
|||||
KNL-225 Mark G. Moloney Equisetin, Reutericyclin and Streptolodygin: Natural Product Lead Structures for Novel Antibiotics |
KNL-226 Debomoy K. Lahiri Seeing a Road from the CAR: Could Effective microRNA “brakes” Slow Down the Trip to Alzheimer’s Disease? |
IL-227 Campbell McInnes Fragment Based Design of Non-ATP Competitive Kinase Inhibitors through REPLACE
|
SL-228 Ian D. Dickey Transcutaneous Applications of Foam Metals
|
IL-229 Ignacio J. Diaz-Maroto Identification of Botanical Origin of Natural Woods Used in Wine Aging |
|||||
1:35 - 1:55 pm |
1:35 - 2:05 pm |
1:30 - 1:50 pm |
1:20 - 1:40 pm |
1:30 - 1:50 pm |
|||||
SL-230 Hidayat Hussain New Strategies for Fighting Malaria
|
IL-231 Frederic Checler Presenilins are Transcriptional Targets of Parkin |
SL-232 Kenneth W. Duncan Targeting the Arginine Methyitransferases |
SL-233 Akio Mori Targeting CD28 Signal for Steroid Resistant Asthma
|
SL-234 James Petrie A New Plant Oil Production Platform: Seed-like Oil Yield from Biomass |
|||||
1:55 – 2:15 pm |
2:05 – 2:35 pm |
1:50 – 2:10 pm |
1:40 – 2:00 pm |
1:50 – 2:10 pm |
|||||
SL-235 Mouloud Kecha Antibacterial Polyketide from the Marine Alga-derived Endophitic Streptomyces sundarbansensis: A Study on Hydroxypyrone Tautomerism |
IL-236 Sultan Darvesh Butyrylcholinesterase as a Diagnostic and Therapeutic Target for Alzheimer’s Disease
|
SL-237 Ernst Schonbrunn Development of Potent Dual Bromodomain-kinase Inhibitors for Cancer Therapy |
SL-238 Xiaoming Wang The Expression of Plasma miR-199a-5p,miR-200c-3p in Gastric Carcinoma and its Clinical Significance |
SL-239 Sang-Soo Kwak Metabolic Engineering of Carotenoids in Transgenic Sweetpotato for Sustainable Development on Global Marginal Lands |
|||||
2:15 - 2:35 pm |
2:35 - 3:05 pm |
2:10 - 2:30 pm |
2:00 - 2:20 pm |
2:10 - 2:30 pm |
|||||
SL-240 Mukhtar Dauda Comparison of In vivo and In vitro Tests of Resistance in Plasmodium falciparum Positive Patients Treated with Artemisinin Based Combination Therapy in Northwestern Nigeria
|
IL-241 Nigel Greig New Pharmacological Tools to Understand and Experimental Drugs to Treat Mild Traumatic Brain Injury and Related Disorders
|
SL-242 Diwan S. Rawat Molecular Hybrids: An Innovative Approach in Drug Discovery
|
SL-243 Weilin Xu The Physical Properties and Biocompatibility of Biomedical Polyurethane Reinforced by Native Silk Fibroin Powder
|
SL-244 Zahid Ali Genetic Stability and Persistence of Morphological Features of Transgenic Pea (Pisum sativum L.) Harboring Na+ Antiporter Against Salt Stress |
|||||
2:35 – 2:55 pm |
3:05 – 3:25 pm |
2:30 – 2:50 pm |
2:20 – 2:40 pm |
2:30 – 2:50 pm |
|||||
SL-245 Mei X. Wu Effective and Lesion-free Cutaneous Influenza Vaccination |
SL-246 Xudong Huang A Brain-permeable Antioxidant Targeting Aβ Amyloid Pathology
|
SL-247 Eileen J. Kennedy Inhibiting EGFR Dimerization Using Triazolyl-bridged Dimerization Arm Mimics |
SL-248 Hyung-Kwon Lim Engineering of Novel Domain Antibody Scaffold Using In vivo Protein Folding Pathway
|
SL-249 Seema Sambrani Bioaugmentation of Crude Oil Spills: Bioremediation with a Microbial Formula Tailored with Selected Solvent Tolerant Native Strain |
|||||
2:55 - 3:30 pm |
3:25 - 3:55 pm |
2:50 - 3:10 pm |
2:40 - 3:00 pm |
2:50 - 3:10 pm |
|||||
KNL-250 Rathnam Chaguturu Scientific Misconduct in Biomedical Sciences
|
IL-251 Jeff Kuret Imaging Agents for Diagnosis of Neurodegenerative Diseases
|
SL-252 Damith G. Udugamasooriya Peptoid-combinatorial Strategies to Target Non-protein Biomarkers in the Tumor Microenvironment
|
SL-253 Ken Saito Biotechnological Approach of MEMS Microrobot System with Artificial Neural Networks Integrated Circuit |
SL-254 Ming Y. Zheng The Significance of Doubled Haploid Production via Microspore Embryogenesis in Plant Biotechnology and Crop Breeding |
|||||
3:30 - 3:50 pm |
3:55 - 4:15 pm |
3:10 - 3:30 pm |
3:00 - 3:20 pm |
3:10 - 3:30 pm |
|||||
SL-255 Stanislav Pavelka Iodothyronine Deiodinases: Determination of their Activities by Novel Radiometric Enzyme Assays
|
SL-256 Cynthia Lemere Alzheimer's Disease Vaccines: Breakthroughs and Setbacks
|
SL-257 Venkat Subramanian Novel Inhibitors and Chemical Probes to Study the Protein Arginine Deiminases (PADs)
|
SL-258 Shlomit Kenigsberg The Need for Optimization: Overview of Extracellular Vesicles (EVs) Isolation Techniques from Small Volumes of Serum and Reproductive Biological Fluids |
SL-259 Satyawati Sharma Bioremediation of Heavy Metal Polluted and Salt Affected Soils Employing Arbuscular Mycorrhizal Fungi |
|||||
3:50 – 4:10 pm |
4:15 – 4:35 pm |
3:30 – 4:00 pm |
3:20 – 3:40 pm |
3:30 – 3:50 pm |
|||||
SL-260 Araz Raoof From Patients Biospecimens to Therapeutic Solutions: New Departure in Drug Discovery
|
SL-261 Jack Rogers Cooperative RNA Modulation of Neurodegenerative Disease Transcripts to Improve Iron Homeostasis while also Providing Anti-amyloid Efficacy |
IL-262 Denise de Oliveira Silva Developing Strategies to Build Combined Diruthenium-pharmaceutical Metallodrugs Targeting Cancer Therapy |
SL-263 Alexander Trofimov Helio-hero Protected Drink-water and Food: The New Possibilities and Perspectives of the Preventive Medicine |
SL-264 Katsuhiro Shiratake Multi-omics Study on Anthocyanin and Resveratrol Accumulations in Grape Berry Skin and Culture Cells
|
|||||
4:10 - 4:30 pm |
4:35 - 5:05 pm |
4:00 - 4:30 pm |
3:40 - 4:00 pm |
3:50 - 4:10 pm |
|||||
SL-265 Shamsher Ali Bottom-up Approaches for Polymeric Vasculature Tissue Constructs and Cellular Microenvironment |
IL-266 Kumar Sambamurti Dietary Restriction to Prevent AD Pathogenesis
|
IL-267 James B. Hoying Microvessel Adaptation and Plasticity in Microvascular Regeneration
|
SL-268 Fayyaz Rasool ATPase 6/8 Gene Assisted Genetic Variability Studies Among the Population of Labeorohita
|
SL-269 Sujing Li Novel Application of Sargassum as a Potential Waste Derived Catalyst for Low Temperature Selective Catalytic Reduction of Nitric Oxides |
|||||
4:30 – 4:50 pm |
5:05 – 5:35 pm |
4:30 – 5:00 pm |
4:00 – 4:20 pm |
4:10 – 4:30 pm |
|||||
SL-270 Elizabeth Sobhia Insights from Molecular Dynamics Studies to Combat Isoniazid – Resistant Tuberculosis
|
IL-271 Weihong Song Prenatal Vitamin A Deficiency Facilitates Alzheimer’s Disease Pathogenesis |
IL-272 Nancy L. Parenteau The Rational Biological Design of Regenerative Therapies and Devices
|
SL-273 Hossain Uddin Shekhar Boosting the Food Functionality (In vivo and In vitro) of Spirulina Grown in Bangladesh by Gamma Radiation: An Inspiring Approach |
SL-274 Ngozi Edoh Evaluation of High β-Carotene Cassava Genotypes at Advanced Trial in Nigeria |
|||||
4:50 - 5:10 pm |
5:35 - 5:55 pm |
5:00 - 5:20 pm |
4:20 - 4:40 pm |
4:30 - 4:50 pm |
|||||
SL-275 Namrita Lall Untangling the Opportunities from South African Plants
|
SL-276 Kamil Kuca Synthesis and Biological Evaluation of Novel Tacrine Derivatives and Tacrine-Coumarin Hybrids As Cholinesterase Inhibitors |
SL-277 Xin Wang Neuroprotective Drug Discovery and Neural Stem Cell Research in ALS |
SL-278 Mian Zhou Determine the Role and Mechanism of Gene Codon Usage in Regulating Protein Expression and Folding
|
SL-279 Kazimierz Strzalka Enzymatic De-epoxidation of Violaxanthin and Diadinoxanthin in the Xanthophylls Cycle Requires Presence of Non-bilayer Lipids |
|||||
5:10 – 5:30 pm |
|
5:20 – 5:40 pm |
4:40 – 5:00 pm |
4:50 – 5:10 pm |
|||||
SL-280 Waseem Hassan Evaluation of Secondary Metabolites, Micro-macro Elements and Antimicrobial Activity of Cinnamomum tamala Leaves
|
|
SL-281 Alessia Cedola X-ray Synchrotron Phase Contrast Tomography for the Investigation of Regenerative Treatment in Neurodegenerative Diseases |
SL-282 Mengyi Ren Metallogenic Information Extract and Prognosis Research of Seafloor Polymetallic Sulfide Resources in Southwest Indian Ocean |
SL-283 Li Xu Co-display of Synergetic Rhizopus oryzae Lipase and Candida rugosa Lipase 1 Biodiesel Production |
|||||
5:30 - 5:50 pm |
|
5:40 - 6:00 pm |
5:00 - 5:20 pm |
5:10 - 5:30 pm |
|||||
SL-284 Stephen G. Ward Pharmacological Manipulation of SHIP-1 Modulates Human T Lymphocyte Adhesion and Migration |
|
SL-285 Robert J. Deans Commercializing Adult Stem Cell Therapeutics for Treatment of Stroke and Acute CNS Injury |
SL-286 Menghao Cai Genetically Shaping Morphology of the Filamentous Fungus Aspergillus glaucus for Production of Antitumor Polyketide Aspergiolide A |
SL-287 Pengcheng (Patrick) Fu Synthetic Biology of Cyanobacteria for Bioethanol Production |
|||||
5:50 - 6:10 pm |
|
|
5:20 - 5:40 pm |
5:30 - 5:50 pm |
|||||
SL-288 Syed W.A. Shah Immunomodulatory Potential of Isolated Constituents from Salix Caprea and Simultaneous Quantification, Method Validation of Five Polar Secondary Metabolites by LC/MS |
|
|
SL-289 Vladimir P. Baklaushev Targeted Delivery of Liposomes and Nanoparticles in High Grade Glioma Cells In vitro and In vivo
|
SL-290 Mohamed M. Ibrahim Bio-saline Agriculture of Salicornia begelovii, New Approaches for Biodiesel Production
|
|||||
COFFEE BREAK:
6:00 – 6:45 pm |
|||||||||
DAY 4: Saturday, July 25, 2015 |
||||||||
Chairman:
D.K. Lahiri |
JOINT PLENARY SESSION |
|||||||
Time |
Speakers |
Titles |
||||||
8:30 - 9:20 am |
Ada E. Yonath (Nobel Laureate) PL-291 |
Advanced Therapeutics while Preserving the Microbiome |
||||||
9:20 - 10:10 am |
Edmond J. Yunis PL-292 |
Specific Anti-tuberculin (IgG) High Levels and Lymphocyte In vitro Proliferation with Tuberculin are Better Indicators of LTBI than TST |
||||||
10:10 - 11:00 am |
Richard L. Atkinson PL-293 |
Current Status of Obesity and the Need for a Paradigm Shift |
||||||
POSTER
SESSION & LUNCH BREAK: 11:00 – 1:00 pm |
||||||||
Locations |
Lecture Hall 201 Level 2 |
Lecture Hall 202 Level 2 |
Lecture Hall 203 Level 2 |
Lecture Hall 204 Level 2 |
||||
Tracks |
Drug Delivery & Targeting
|
Innovative Drug Discovery & Nanotechnology / Inflammation and Immunology |
Plant & Environment / Neurodegenerative Disorders |
Pharmaceutical Biotechnology / Other Areas (Nanobiotechnology, bio-safety) / Regenerative Medicine / Industrial & Manufacturing / Academic CRO – Industrial Collaborations in Drug Discovery |
||||
Chairman: V.Weissig Co-Chairman: A.Puri |
Chairman: E.S.Don Co-Chairman: M.C.Vasudev |
Chairman: B.Dewprashad Co-Chairman: J. Rogers |
Chairman: H.H.-C.Siebert Co-Chairman: E.A.R.Rosa |
|||||
1:00 – 1:30 pm |
1:00 – 1:30 pm |
1:00 – 1:20 pm |
1:00 – 1:30 pm |
|||||
IL-294 Volkmar Weissig Specific Delivery of Drugs to Mitochondrial Targets: Manipulating Mitochondrial Functions |
IL-295 Silvia De Paoli Modulatory Effects of Plasma Protein Corona on the Interactions of Nanoparticles with Human Blood Platelets |
SL-296 Surinder Singh Metabolic Engineering of Long Chain Omega-3 Fatty Acids for the Oilseed Industry |
IL-297 Habil H.-C. Siebert New Perspectives in Nanomedicine and Nanopharmacology
|
|||||
1:30 - 2:00 pm |
1:30 - 1:50 pm |
1:20 - 1:40 pm |
1:30 - 2:00 pm |
|||||
IL-298 Anu Puri Phototriggerable Lipid Assemblies and their Applications for Dual Drug Delivery |
SL-299 Stephan T. Stern Generic Nanomedicines: Pharmacokinetic and Bioanalytical Evaluation |
SL-300 Balaji M. Panchal Inhibition of Chilo Partellus (Lepidoptera: Pyralidae) Gut Proteases by Compounds from Ipomoea batata |
IL-301 Tun Liu A Comprehensive Approach to Understand Glycosylation of Monoclonal Antibodies |
|||||
2:00 - 2:20 pm |
1:50 - 2:10 pm |
1:40 - 2:00 pm |
2:00 - 2:20 pm |
|||||
SL-302 Gerard G.M. D’Souza Three Dimensional Cell Culture Models of the Solid Tumor Microenvironment for the Testing of Pharmaceutical Nanocarriers |
SL-303 Marina A. Dobrovolskaia Immunological Properties of Engineered Nanomaterials and Challenges with their Preclinical Characterization |
SL-304 Shree Prakash Panday Plant Stress Adaptation, Signaling and the Regulatory Small RNA Pathways: Evolution and Functional Specialization |
SL-305 Hala A. Amin Whole Cell Biocatalyst for Soyasapogenol B Production from Soybean Saponin |
|||||
2:20 – 2:40 pm |
2:10 – 2:30 pm |
2:00 – 2:20 pm |
2:20 – 2:40 pm |
|||||
SL-306 Aruna Chhikara Co-delivery of Etoposide and Vorinostat Using Poly (Ethylene Glycol) Based Biodegradable Nanogels |
SL-307 Jiwen Zheng Challenges and Considerations in Nano-drug Characterization
|
SL-308 Shifted to SL-119(a) |
SL-309 Bushra H. Kiani Artemisinin Production in Artemisia annua and Artemisia dubia Following Transformation with the Rol ABC Genes and Elucidation of the Sites of its Synthesis |
|||||
2:40 - 3:00 pm |
2:30 - 2:50 pm |
2:20 - 2:40 pm |
2:40 - 3:00 pm |
|||||
SL-310 Josephine S. Modica-Napolitano Treatment Strategies that Enhance the Efficacy and Selectivity of Mitochondria-targeted Anticancer Agents |
SL-311 Gökhan Savaroğlu The Effect of Ultrasound of Amplitute and Expose Time on the Particle Size and Solubility of Naproxene Sodium |
SL-312 Ihuoma Okwuonu Effect of Transgene Copy Number on Vector Backbone (VBB) Integration in Transgenic Cassava Genome |
SL-313 Edvaldo A.R. Rosa Paper-attached Yeast Biofilms. An Alternative for Living Biocatalysts Growth |
|||||
3:00 – 3:20 pm |
2:50 – 3:10 pm |
2:40 – 3:00 pm |
3:00 – 3:20 pm |
|||||
SL- 314 Shana Kelley Mitochondrial Targeting of Therapeutics
|
SL-315 Zhi-Ren Liu Development of Protein Agent Targeting Integrins avb3 at a Novel Site by Rational Protein Design |
SL-316 Benjamin Wolozin Stress Granules and Neurodegeneration: Novel Targets for Therapy in Amyotrophic Laterial Sclerosis and Alzheimer’s Disease |
SL-317 Catherine Michaux Towards a Universal Method for Protein Refolding
|
|||||
3:20 - 3:40 pm |
3:10 - 3:30 pm |
3:00 - 3:20 pm |
3:20 - 3:55 pm |
|||||
SL-318 Mu-Ping Nieh Single-step Formation and Cellular Response of Vesicles and Disk-like Bicelles |
SL-319 Elena S. Don Release-active Antibodies are Innovative Antibodies-based Drugs: New Way to Quality Assessment |
SL-320 Nipun Chopra Role of Neprilysin in Alzheimer’s Disease
|
KNL-321 Ali Khademhosseini Engineered Hydrogels for Regenerative Medicine Applications |
|||||
3:40 - 4:00 pm |
3:30 - 4:00 pm |
3:20 - 3:40 pm |
3:55 - 4:15 pm |
|||||
SL-322 Upal Roy Prolonged Acting Nanomedicine Based Anti-HIV Drug Delivery Targeting Gut Associated Lymphoid Tissues |
IL-323 Thomas J. Webster Advances in Nanotechnology for Drug Delivery
|
SL-324 Debomoy K. Lahiri / Frederic Checler Short Discussion
|
SL-325 Amin A. El-Meligi Nano-Layered Materials for Drug Delivery and Trapping Harmful Anions in Tumor |
|||||
4:00 – 4:20 pm |
4:00 - 4:20 pm |
3:40 – 4:00 pm |
|
|||||
SL-326 Stephan Stern Nano-formulation Modified Drug Pharmacokinetics and Therapy |
SL-326(a) Nicholas Mark Valiante A Medicinal Chemistry Approach to Gaining Pharmacological Control of Immunity |
SL-327 Debomoy K. Lahiri Short Discussion on CAR |
|
|||||
4:20 – 4:40 pm |
4:20 - 4:40 pm |
|
|
|||||
SL-328 Amit Joshi Light Triggered Nanoparticle Theranostics for Cancer
|
SL-328(a) Charles J. Malemud PI3K/Akt/mTOR Signaling: A Potential Target for Inducing Apoptosis in Immune-Mediated Arthritis |
|
|
|||||
4:40 – 5:00 pm |
|
|
|
|||||
SL-329 Shahinaz Shalaby Magnetofection Enhancing Suicidal Gene Therapy of Uterine Fibroid Tumor Cells |
|
|
|
|||||
COFFEE BREAK:
5:00 – 5:30 pm |
||||||||
CASH PRIZE
ANNOUNCEMENT FOR THE BEST POSTER AT 5:30 P.M. (Poster Presenter’s
Presence is Essential to Receive the Cash Award and Certificate of Merit) PL: Plenary
Lecture ::: KNL: Key Note Lecture ::: IL: Invited Lecture ::: SL: Session
Lecture |
||||||||